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Abstract 
In asparagine-linked glycosylation, a complex carbohydrate 
is transferred by oligosaccharyl transferase to an asparagine in 
the consensus triad -Asn-Xaa-Thr/Ser-. The mechanism of this 
transfer is not fully understood but appears to involve 
nucleophilic attack by the carboxyamido group of asparagine at 
the anomeric carbon of the sugar with concomittant displacement 
of dolichol pyrophosphate. Central to understanding the 
mechanism of N -glycosylation is ascertaining how the reactivity of 
a relatively poor nucleophile, the carboxyamido group, can be 
enhanced. 
To increase the amide-nitrogen nucleophilicity, the amide 
resonance interaction must be disrupted. The necessity for a 
hydroxy amino acid two residues from the asparagine suggests 
that this residue may participate in a hydrogen bonding 
interaction. If the hydroxyl group is hydrogen bonded to the 
amide oxygen of the asparaginyl side chain, this interaction would 
increase the pKa of the amide protons through disruption of the 
amide resonance. Further, a general base could then abstract a 
proton, thereby increasing the nucleophility of the amide nitrogen. 
If such a hydrogen bonding array is crucial to the 
mechanism of the transfer, the conformation of the peptidyl 
substrate must allow for the asparagine and threonine side chains 
to be in close proximity. 
A series of tripeptides that satisfy the -Asn-Xaa-Thr/Ser-
primary sequence requirement were synthesized and examined as 
vi 
potential acceptors in an oligosaccharyl transferase assay. It was 
demonstrated that the dominant solution conformation of 
substrates in glycosylation were Asx-turns. This conformation is 
stabilized by an interaction between the asparaginyl 
carboxyamido oxygen and the backbone amide proton of the 
hydroxy amino acid residue. The Asx-turn is a common structural 
motif in peptides and, in this case, brings the carboxyamido and 
hydroxyl groups within hydrogen bonding distance. Using 
constrained peptidyl analogs, the Asx-turn was demonstrated to 
be the bioactive conformation in N-glycosylation. 
Further, peptidyl analogs were used to probe the mechanism 
of glycosylation. A mechanism which is consistent with both the 
conformational and kinetic data obtained in these studies is 
proposed. 
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GENERAL METIIODS 
Nuclear magnetic resonance spectra were recorded on a 
Bruker WM-300 (IH, 300 MHz; 13C, 75 MHz) or a Bruker AMX-500 
(IH, 500 MHz; 13C, 125 MHz) spectrophotometer. IH and 13C NMR 
shifts are reported in parts per million (ppm) down field from 
tetrametylsilane as an internal standard on the /) scale. All 2-D 
ROESY spectra were recorded on a Broker AMX-500 (500 MHz). 
Analytical thin layer chromatography (TLC) was performed 
with 0.25 mm thick E. Merck pre-coated plates, silica gel 60 F-
254. Preparative TLC (PTLC) separations were carried out on 1.0 
mm thick E. Merck pre-coated plates, silica gel 60 F-254. 
Flash chromatography was carried out using Baker 40 ~m 
silica gel according to the general procedures of Still et al. (1). 
Reagents and solvents were commercial grade and used as 
supplied. Where anhydrous conditions were employed, solvents 
were dried before use following the general procedures reported 
by Perrin and Armarego (2). 
Liquid scintillation counting was performed on a Beckman 
LS 5000 TD and reported as disintegrations per minute (dpm). 
Aqueous samples were counted with Ecolite (ICN) scintillation 
fluid, organic samples were counted in Betamax (ICN) , and 
proteinaceous pellets were dissolved first in Solvable (DuPont) 
before counting in Formula 989 (DuPont) scintillation fluid. 
2 
High pressure liquid chromatography (HPLC) was performed 
on a Beckman dual wavelength HPLC. 
Centrifugation was performed on a Beckman Supers peed LS-
35 equipped with a cooling system. 
1 Still, W.C.; Kahn, M.; Mitra, A. "Rapid Chromatographic 
Technique for Preparative Separations with Moderate 
Resolution," J. Org. Chern. 1978,43, 2923. 
2 Perrin, D.D.; Armarego, W.L.F. Purification of Laboratory 
Chemicals, 3rd ed., Pergamon Press: New York, 1988. 
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Chapter 1 
Background Information on 
Asparagine-Linked Glycosylation 
4 
Glycoproteins are a diverse group of biopolymers which are 
ubiquitous constituents of cells. They differ from other proteins by 
having oligosaccharide chains covalently attached to the polypeptide. 
Glycoproteins range in molecular weight from 15,000 to over 1 
million, usually they contain fifteen or fewer sugar units per 
covalently attached oligosaccharide chain, and their carbohydrate 
content can range from 1-85% by weight. Glycoproteins are present 
in most organisms, including: plants, bacteria, fungi, viruses, and 
animals where they serve a variety of functions . For example, 
salivary mucins have a lubricating function which is related to their 
elasticity. In other glycoproteins, the carbohydrate units serve to 
protect the peptide backbone from proteolysis and denaturation. Of 
major interest is the apparent role of membrane bound glycoproteins 
(and glycolipids) located on the outer cell surface to serve as 
receptors. These membrane-bound proteins may influence cell-cell 
interactions, and thus be of importance in growth, differentiation, 
and malignancy. Sugars located at the cell surface also appear to 
function in cell adhesion, mitogenic stimulation, cytotoxic response, 
. as well as a variety of other biological phenomena. 
Nine different sugar residues are found in the oligosaccharide 

































Figure 1-1 Sugar residues found in glycoproteins. 
Glucose (Glc) is found mainly in collagen, but galactose (Gal) and 
mannose (Man) are more common and ate widely distributed. The 
two most frequently found sugars are N-acetylglucosamine (GlcNAc) 
and N-acetylgalactosamine (GaINAc). Fucose (Fuc), arabinose (Ara), 
xylose (Xyl), and the sialic acids (Sial) are also found. In general, N-
acetylhexosamines are found near the attachment site of the 
oligosaccharide chain to the protein, whereas sialic acid residues are 
located more distal in the chain, frequently at terminal sites. 
6 
The oligosaccharide chains are attached to the polypeptide 
backbone of glycoproteins at one of five amino acid residues: 
asparagine, serine, threonine, hydroxylysine, or hydroxyproline. 
Depending on the attachment site of the oligosaccharide, the 
glycosyl-peptide bond can be either of the 0- or N-type. Examples of 
both types of glycoproteins are shown in Figure 1-2 (1). 
a) 
Asn 
• = GlcNAc ... = Man 
+= GalNAc 0 = Gal 
b) 
Thr/Ser 
Figure 1-2 Examples of N-linked (a) and O-linked (b) sugar chains 
of glycoproteins. Structures were selected to contrast 
the two classes of sugar chains, which show differences 
in the core sequence, and similarities in the peripheral 
sequences . 
These examples were selected to contrast the two types of 
glycoproteins. N-linked glycoproteins share a common Man3GlcNAc2 
core sequence (shown in bold) which is attached to an asparagine 
7 
residue within a polypeptide. In contrast, there is no single, common 
carbohydrate core in O-linked glycoproteins. The core sugar residue 
can be attached to the hydroxyl group of threonine, serine, 
hydroxyproline, or hydroxylysine. Further, this core sugar can be 
any of the nine monosaccharides. Sequence diversity is also acquired 
through extension of the oligosaccharide chains attached to the core. 
For both types of glycoproteins, this extension commonly occurs from 
the use of a (GaI131,4)3GlcNAcIH,3 sequence repeat (shown in plain 
text) which is decorated with various terminal sugars (shown in 
italics). Typically the terminal sugars are a-linked Sial, Fuc, Gal, 
GlcNAc residues, attached either singly or in combination to one or 
more hydroxyl groups of the core structure. Branching can also occur 
by the attachment of extension sequences to galactose residues at 
both the 3 and 6 positions (2). 
Glycoproteins are synthesized by the same machinery that 
produces all other proteins. The biosynthesis event occurs within an 
intracellular membrane system composed of the endoplasmic 
reticulum, transfer vesicles, the Golgi apparatus, and secretory 
vesicles. During translation, glycosylation, processing, and transport, 
glycoproteins are completely isolated from the cytoplasm. 
Our current understanding of N-linked glycoprotein translation 
is that it begins with the attachment of mRNA to ribosomes in the 
cytoplasm (Figure 1-3)(3). The attachment of free ribosomes to the 
ER membrane is mediated by a signal recognition particle. A signal 
sequence (containing about 16 residues) is translated and serves to 
guide the forming protein through the membrane bilayer into the 
lumen of the ER. This sequence is subsequently cleaved. Transfer of 
8 
preformed oligosaccharide units from a lipid intermediate to 
asparagine residues, to form N-glycosidic linkages, probably occurs 
very soon after the polypeptide emerges on the lumen side of the ER. 
The glycoprotein then migrates to the Golgi apparatus where 
further trimming and elongation of the oligosaccharide moiety occurs 
as well as attachment of oligosaccharide units to hydroxyl residues to 
form O-glycosidic linkages. Once elongation is completed within the 
Golgi apparatus, the mature glycoprotein migrates towards the 
plasma membrane within a transport vesicle. The vesicle membrane 
fuses with the plasma membrane and secretory glycoproteins are 
extruded from the cell. Membrane glycoproteins probably become 
part of the plasma membrane by a lateral diffusion process . These 
glycoproteins are inserted into the membrane asymmetrically, with 
their carbohydrate moieties located on the outside surface of the cell. 
The biosynthesis of N-glycosidic units proceeds through a 
different mechanism from that of most of the O-glycosidic 
carbohydrate units, although the primary sugar donors in the 
synthesis of both classes of carbohydrate units are sugar nucleotides 
and the enzymes involved are glycosyltransferases. The simplest 
route involves the direct transfer of a carbohydrate residue from a 
sugar nucleotide complex to the polypeptide chain or onto a forming 
oligosaccharide component. This route predominates in 0-
glycosylation where it occurs as a post-translational modification In 
the Golgi apparatus. It is also seen in the later processing of N-
glycoproteins. 
The second route involves the formation of an intermediate 
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SNCP 
Figure 1-3 Cellular location of events in the biosynthesis of 
gl ycoproteins. 
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for the oligosaccharide chain synthesized on it. This route is used for 
N-glycosylation. Synthesis of N-glycosidic units can be divided into 
three distinct steps: 1) assembly of a lipid-linked oligosaccharide 
intermediate, 2) transfer of the oligosaccharide from the carrier to 
the growing polypeptide chain, and 3) trimming of the carbohydrate 
unit and addition of peripheral sugars. 
For the synthesis of N-linked glycoproteins, the lipid linked 
oligosaccharide intermediate is Glc3Man9(GlcNAc)z-P-P-Dolichol. This 
precursor unit is assembled by a series of reactions onto a lipid 
carrier, dolichol phosphate (4). Dolichol phosphate is a polyisoprene 
derivative located in the cell membrane. The number of isoprene 
units in the polyprenol is unusually high and varies from 17 to 21 in 
animals, from 14 to 24 in plants, yeast, and fungi, and from 10 to 12 
in bacteria. The length of the fully extended form would be close to 
100 A. For comparison, oleic acid, a common constituent of 
phospholipids is only 25 A. Clearly the biological conformation is 
very unlikely to be the extended form since the width of the ER 
membrane is generally 40 to 60 A. The conformation has been 
shown to be comprised of a central coiled region flanked by two 
flexible arms (5). Dolichol serves to firmly anchor the carbohydrate 
close to the lumen side of the ER membrane near to the site of the 
emerging polypeptide. In animals, three of dolichol's isoprenol units 






Figure 1-4 Structure of dolichol phosphate (n=9-15). 
Also the a-isoprenol unit is saturated and of the two possible 
enantiomers, only the S-form of dolichol phosphate is involved in 
glycoprotein biosynthesis (6). 
The assembly of the oligosaccharide begins with the reversible 
transfer of N-acetylglucosamine I-phosphate from UDP-GlcNAc to 
Dolichol-P (Figure 1-5, 1), followed by the irreversible transfer of N-
acetylglucosamine, also from UDP-GlcNAc, to the GlcNAc-P-P-Dol 










GIc3-M an9-(GleN Ae )z-prolein 
6 
Figure 1-5 Dolichol phosphate cycle 
Mans-(GleN Ae)z-P-P-Dol 
Yan-p-DOI ~ GDP-Man 
Man9-(G leN Ae )z-P-P-Dol 
l.- 5a 5/ GIc-P-Dol_ UDP-GIc 
GIq -Man9-( GleN Ae)z-P-P-Do I 
Protein 
The J3-linked mannose residue of the pentasaccharide core is 
transferred directly from GDP-Man to (GlcNAch-P-P-Dol (Figure 1-5, 
3). Attachment of the remaining mannose residues, as well as of the 
three glucoses, is believed to proceed via the corresponding dolichol 
phosphate derivatives (Figure 1-5, 4 & 5), formed respectively from 
GDP-Man and UDP-GIc (Figure 1-5, 4a & Sa). The ultimate product 
of this cycle is GIc3Man9(GIcNAch-P-P-DoL The oligosaccharide is 
transferred en bloc from the lipid carrier to the nascent polypeptide 
(Figure 1-5, 6). Thus the final step of the dolichol cycle results in the 
transfer of a mannose-rich oligosaccharide chain to a polypeptide. 
Most of the reactions of the dolichol phosphate cycle proceed 
with inversion of configuration. However since GIcNAc-P-P-Dol is 
13 
formed by a condensation of two phosphates, the sugar-I-phosphate 
bond is not broken, and thus this sugar remains a-linked. Inversion 
of configuration of the bond between the oligosaccharide and the 
pyrophosphate must therefore occur upon transfer of the preformed 
oligosaccharide to the protein acceptor resulting in the formation of a 
G IcN Ac-I3-Asn linkage. 
Strong evidence in support of the dolichol phosphate cycle 
comes from experiments with inhibitors of glycosylation. The most 
effective of these is tunicamycin, a glucosamine-containing antibiotic 
isolated from Streptomyces lysosuperiJicus, which inhibits the first 
step in the dolichol phosphate cycle, the formation of GlcNAc-P-P-Dol 
(7). Other inhibitors include 2-deoxyglucose, 2-fluoroglucose, and 2-
fluoromannose (8). These inhibitors compete for available dolichol 
phosphate and lead to formation of altered intermediates. However, 
these compounds are not recognized by the glycosyl transferase and 
therefore inhibition of the overall reaction occurs as dolichol 
phosphate supplies become exhausted. 
The transfer of the precursor oligosaccharide to the peptide 
substrate occurs co-translationally and involves a complex interplay 
among the nascent polypeptide chain that is being translated through 
the ER membrane, a polar oligosaccharide chain attached to an 
extremely hydrophobic lipid carrier, and the enzyme, oligosaccharyl 
transferase. The latter two components are embedded within the ER 
membrane. 
Although general information about the overall pathway of N-
linked glycosylation is available, our understanding of the properties 
of the oligosaccharyl transferase involved in this process have been 
14 
restricted by our inability to purify this enzyme away from its 
membrane environment. Attempts to purify this enzyme by classical 
techniques such as detergent solubilization followed by ion-exchange 
chromatography, gel filtration, etc., have led to complete loss of 
enzymatic activity (9). Presumably this loss of activity reflects that 
the enzymatic reaction occurs at the interface of the hydrophobic 
environment of the phospholipid bilayer of the ER. Recently it has 
been shown that oligosaccharyl transferase activity is associated with 
a complex composed of two ribophorins and a 48 kd protein (10). 
Thus it is not surprising that conventional manipulations during 
purification lead to a loss of activity, since these methods would 
disrupt the multi-subunit complex. 
The known properties of oligosaccharyl transferase include a 
requirement for divalent cations (with Mn2+ being the most 
effective), an optimum pH between 7 and 7.5, and its association 
with the membrane for maintenance of enzymatic activity (9). Until 
the enzyme can be purified in its active form, specific information 
regarding the mechanism of the oligosaccharide transfer step must 
be gleaned from substrate studies of the lipid-linked oligosaccharide 
and of the polypeptide acceptor. 
The affinity of oligosaccharyl transferase for oligosaccharyl-P-
P-dolichol seems to diminish as the size of the oligosaccharide 
decreases. Thus, the "normal" substrate, GlC3Man9GlcNAc2-P-P-Dol, 
is a more effective substrate than shorter versions (11). However, 
shorter lipid-linked oligosaccharides can be transferred to 
polypeptide acceptors using membrane fractions isolated from a 
variety of sources (12-15). In yeast membrane preparations, the 
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Km value for Glc3Man9GlcNAc2-P-P-Dol of 0.5 J.1M does not differ 
significantly from that for GlcNAc2-P-P-Dol of 1.2 J.1M (13). Thus 
oligosaccharyl transferase seems to have a rather broad binding 
specificity with respect to the lipid-linked oligosaccharide. 
It is unclear how the presence of the "normal" lipid-linked 
oligosaccharide substrate influences the recognition of the peptidyl 
substrate. Studies with oligosaccharyl transferase in yeast 
membrane preparations indicate that the structure of the lipid linked 
oligosaccharide affects the apparent Km of the enzyme for the 
peptidyl substrate. The Km of a peptide in the presence of "normal" 
lipid-linked oligosaccharide substrate, is ten fold lower than the Km 
observed when the unnatural substrate, GlcNAc2-P-P-Dol, is present 
(13) . 
Much more information is available concerning the specificity 
of oligosaccharyl transferase for the peptidyl substrate. It is now 
well established that a prerequisite for glycosylation is the 
occurrence of the acceptor asparagine in the tripeptide sequence, 
-Asn-Xaa-Thr/Ser-, where Xaa can be any of the 20 naturally 
occurring amino acids except proline (16). Only specific -Asn-Xaa-
Thr/Ser- sites in a polypeptide are glycosylated. Most possible 
acceptor sites that become exposed on the lumenal side of the ER 
membrane are efficiently glycosylated, but some sites are never 
utilized. Gavel and von Heijne (17) have presented a detailed 
statistical study of glycosylated and non-glycosylated -Asn-Xaa-
ThrlSer- sites collected from the literature and from the NBRF-PIR 
database. Their study suggests that the -Asn-Xaa-Thr/Ser- signal 
leads to glycoslyation approximately thirty percent of the time. 
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Their study also demonstrated that -Asn-Xaa-Thr/Ser- sites that are 
located near the C-terminus or which contain proline on either side 
of the hydroxyl amino acid residue are often not glycosylated. 
Experiments with ovalbumin have shown that co-translational 
glycosylation cannot take place until about 45 residues have been 
added beyond the glycosylation site (18). Therefore the bias of 
glycosylated -Asn-Xaa-Thr/Ser- sites towards the N-terminus may 
indicate that glycosylation occurs more easily when the nascent 
polypeptide is still firmly anchored in the ER membrane. 
Alternatively, the higher percentage of acceptor sites at the N-
terminus may reflect that N-terminal sites spend more time In the 
lumen of the ER where both the sugar substrate and the transferase 
are situated. Also, C-terminal sites may be inaccessible to 
glycosylation if significant folding of the polypeptide has occurred 
during the translation event (19). 
Further corroboration that accessibility of the acceptor site IS 
important for glycosylation was provided by studies with 
polypeptide fragments of known glycoproteins which contained 
unglycosylated acceptor sites in their native form (Table 1-1) (20). 
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Table 1-1 Glycosyl acceptor properties of unglycosylated acceptor 
SItes m k I . nown glVCoorotems. 
acceptor upon 
protein potential site denaturation? 
Ovalbumin -N311LS- yes 
a-Lactalbumin -N4SQS- yes 
-N7dS- yes 
RNase A -N34LT- yes 
DNase -NI03DS- yes 
Prolactin -N31LS- yes 
Triosephosphate -NI95VS- yes 
isomerase 
DNase -N103DS- no 
Catalase -N242LS- no 
-N437VT- no 
-N479FS- no 
Concanavalin A -NllSST- no 
-N162GS- no 
Elastase -N66GT- no 
-NI23NS- no 
-N215VT - no 
Glyceraldehyde-3P- -NI46AS - no 
dehydrogenase 
Trvpsinogen -N 151SS- no 
Carboxypeptidase A -N90PS- no 
Alcohol -N300LS- no 
dehydrogenase 
In all thirteen cases examined, it was shown that the polypeptides 
were inactive as acceptors in their native state. In contrast, after 
denaturation, reduction, and derivatization of the sulfhydryl groups, 
six of the thirteen fragments were acceptors in oligosaccharyl 
transferase assays. This suggests that the polypeptide must be 
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unfolded to serve as an acceptor. However, mere disruption of the 
tertiary structure is not always sufficient to allow enzymatic 
glycosylation. The remaining seven peptides were not substrates. 
No correlation is evident between enzymatic activity and the 
distribution of amino acids surrounding the -Asn-Xaa-Thr/Ser- site. 
However, cleavage of concanavalin A and catalase with cyanogen 
bromide provided mixtures of fragments with acceptor properties 
(21) suggesting that the inability of these polypeptides to be 
glycosylated may be due to blockage of the acceptor site by folding 
of the polypeptide and supporting the hypothesis that secondary 
structure plays a critical role in glycosylation. 
Further studies with synthetic peptides have demonstrated 
that the conformation of the polypeptide is a fairly crucial element of 
acceptor ability. Synthetic peptides have been shown to serve as 
acceptors for dolichol-dependent glycosylation catalyzed by 
microsomal fractions from pig thyroid (14), rat liver (15), and hen 
oviduct (12). Synthetic peptides containing as few as three amino 
acid residues can serve as substrates provided that the carboxyl and 
amino termini are blocked (15). The affinity of oligosaccharyl 
transferase increases with the length of the polypeptide acceptor. 
The role of the central amino acid residue, Xaa, in the acceptor 
sequence was examined by substituting this position with five 
different residue in the synthetic peptide, -Tyr-Asn-Xaa-Thr-Ser-
Val- (22). It was found that similar levels of glycosylation occurred 
when Xaa was Gly, Leu, or Cys; whereas, the level was significantly 
lower when Xaa was Asp. and the peptide was not glycosylated when 
Xaa was Pro. Proline differs from other amino acids in two 
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significant aspects. First, it is an imino acid. Thus if the backbone 
amide proton of the central residue is important for binding, a 
peptide containing proline as the central residue could not bind. 
Second, proline's ring structure severely limits the torsional angles 
along its backbone. Thus it is also possible that a specific 
conformation is required for enzymatic activity and proline prevents 
the polypeptide from attaining this conformation. 
The effects of conformational limitations on glycosylation were 
further studied by examining the enzymatic activity of pep tides 
containing two cysteine residues in different positions within a 
polypeptide. Disulfide ring formation provided cyclic peptides of 
various sizes (23). This study demonstrated that the linear analogs 
were glycosylated more actively than their cyclized counterparts. 
Additionally, as the size of the ring expanded, the levels of 
glycosylation of the cyclic analogs approached those of their linear 
analogs. The formation of the disulfide bridge was apparently either 
blocking access to the acceptor site or preventing the polypeptide 
from adopting a conformation which could be recognized by the 
enzyme. 
Conformation and accessibility are not the only factors which 
influence glycosylation. There is also an absolute requirement for a 
hydrogen-bonding moiety in the side chain of the third residue 
within the acceptor sequence. In vitro, the Asn residue in -Asn-Xaa-
Thr- is glycosylated 40-fold more effectively than -Asn-Xaa-Ser-. In 
vivo, additional factors must affect the rate because the frequency of 
glycoproteins containing glycosylated -Asn-Xaa-Ser- sites is only 3-
fold lower than -Asn-Xaa-Thr- sites (24). The H-bonding character 
20 
of the hydroxyl group is thought to play a crucial role in the 
interaction of the enzyme with the acceptor site. Marshall (16) 
proposed that the hydroxyl group of the hydroxyl amino acid could 
be hydrogen bound to the asparagine carboxyamido oxygen as shown 
in Figure 1-6a. He suggested that the function of this 
H~ 
J.N(~J::X:-~t 
1 H 0 : H 0 
Y 
Figure 1·6 Hydrogen bonding array proposed by Marshall. 
hydrogen bonding array is to stabilize the conformation which is 
recognized by the enzyme. However, the role of the hydroxyl group 
appears to be more extensive and seems to be directly involved in 
the mechanism of the transfer. 
The overall reaction which is catalzyed by oligosaccharyl 
transferase is shown in Figure 1-7. 
HOI H 0 
rN~NIN0 





o Oligosaccharyi .. 
OH 0 0 transferase 
OH II II 
o AcHN I I 
OH 0 - O-
RO 
NHAc 
Figure 1·7 Overall reaction catalyzed by oligosaccharyl transferase 
(R=oligosaccharide ). 
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This reaction is unusual because its mechanism appears to involve 
nucleophilic attack by the l3-carboxyamido group of the Asn side 
chain at the anomeric carbon of the sugar with concomitant 
displacement of dolichol pyrophospate. The reaction results in 
formation of a N-glycosidic bond. Normally a l3-carboxyamido 
nitrogen atom of the type found in an Asn residue would lack 
significant nucleophilic character. Therefore, it seems that the Asn 
nucleophilicity must be augmented prior to glycosylation. 
Bause proposed an alternative model (Figure 1-8) to explain 
how the carboxyamido nitrogen could acquire nucleophilic 
properties. 
o H H 
;:)
' , 
o ;~O~ ~ 
L)l"N . N.Ay + r -H 0 : H 0 
r-
Figure 1-8 Hydrogen bonding array proposed by Bause. 
Bause accepted that the presence of the hydroxyl group must be 
crucial to binding as proposed by Marshall, but he pointed out that in 
Marshall's model the orientation of the hydrogen bond results in a 
net decrease in the nucleophilicity of the nitrogen electron pair with 
a corresponding increase in N-H acidity. Bause proposed that the 
hydroxy amino acid side chain functions instead as a hydrogen bond 
acceptor and the amide side chain of the asparagine residue serves 
as a donor. As a result of this interaction the nucleophilicity of the 
22 
amide nitrogen is increased, providing a reactive acceptor for the 
glycoside. 
In support of this model is the finding that a tripeptide 
containing epoxyethylglycine substituted for the hydroxy amino acid, 
is an irreversible inhibitor of oligosaccharyl transferase (25). In 
terms of Bause's model, the epoxide mimics the function of the 
hydrogen bond acceptor, but in this process a basic residue in the 




o N~H ,,( ~O NH-sugar B-Enzyme 
H.----:O~ H0x.-o HO H 0 HO H 
p--~ 0 N--('~ ° N+ • p--~ ° N'f'~ ° N+ r oligosaccharyl r 
transferase 
Figure 1·9 Proposed reaction mechanism for the inhibition of 
oligosaccharyl transferase by an epoxide containing 
peptide. 
With respect to the other essential residue within the acceptor 
sequence, the asparagine side chain is an absolute requirement for 
recognition by oligosaccharyl transferase. Substitution of asparagine 
with glutamine or N-methylasparagine destroys the acceptor activity 
of the marker sequence (24). It has also been shown that synthetic 
peptides containing threo-j3-fluroasparagine are extremely poor 
substrates for in vitro glycosylation, with V max/Km values only 1% of 
the analogous Asn-containing peptides (27). 
From the foregoing account, it is clear that enormous progress 
has been made in our knowledge of the chemistry and biology of 
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glycoproteins. Not surprisingly, these findings have raised new 
questions. Of particular interest are those questions regarding the 
biosynthesis of the N-glycoproteins. The work described within this 
thesis was aimed at answering two questions. 1) What is the 
specific conformation of the polypeptide acceptor which the enzyme 
recognizes? and 2) What is the mechanism by which the 
carboxyamido nitrogen of the asparagine side chain becomes 
activated for attack on the lipid-linked oligosaccharide? 
Our approach to answering the first question was to examine a 
series of flexible peptides which differed by subtle perturbations in 
their conformation. These peptides were examined for substrate 
properties with an enzyme assay (described in chapter 2). 
Computational modelling of hexapeptides with known glycosyl 
acceptor properties are reported in chapter 3. One- and two-
dimensional NMR techniques were employed to ascertain common 
structural features of the acceptors and the non-binders. The 
identification of the probable recognition motif, an Asx-turn, is 
discussed in chapters 4. To further confirm that this motif was 
indeed the recognition element, constrained peptidyl analogs were 
synthesized and examined (chapter 5). 
In approaching the second question, a mechanism which is 
consistent with features of this conformational motif is presented in 
chapter 6. Peptides in which the asparagine residue was replaced 
with several unnatural residues were used as mechanistic probes . 
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The core portion of the carbohydrate sidechain of N-linked 
glycoproteins is biosynthesized by microsomal membrane-associated 
enzymes as a complex oligosaccharyldiphosphoryldolichol derivative 
and is subsequently transfered en bloc to specific asparagine 
residues within a forming polypeptide chain. Selected enzymes of 
the dolichol pathway have been studied in soluble form after 
extraction from microsomal membranes of a variety of tissues (1). 
However the enzyme involved in the final step in this series of 
reactions, the transferase responsible for catalyzing the attachment 
of the oligosaccharide to the asparaginyl residue of the protein to 
form the glycosamine linkage, has only been studied in intact 
membrane preparations. Information concerning the transferase has 
been restricted to kinetic studies of substrates using enzyme isolated 
as crude microsomal fractions. 
The action of this enzyme was first demonstrated by observing 
the transfer of an oligosaccharide moiety from a radiolabelled lipid-
linked oligosaccharide to denatured forms of three secretory 
proteins: ovalbumin, a-lactalbumin, and ribonuclease A (2). A 
membrane fraction isolated from hen oviduct was used as a source of 
the enzyme. The radiolabelled protein product was shown to have 
increased molecular weight, consistent with attachment of an 
oligosaccharide side chain. 
Further attempts to characterize the transferase have utilized 
microsomes isolated from thyroid (4), yeast (5), and liver (6) as 
sources of the enzyme. Generally, transferase activity has been 
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demonstrated by determining the amount of radiolabel transfer that 
has occurred in mixtures of 3H- or 14C-Iabeled 
oligosaccharyldiphosphoryldolichol and unlabeled peptide acceptors. 
However these studies have been hampered by a lack of a reliable 
source of the radiolabeled oligosaccharide donor. 
The oligosaccharide donor in vivo is Glc3Man9(GlcNAch-P-P-
Dol. This complex donor is biosynthesized by a series of reactions 
onto a lipid carrier, dolichol phosphate (7). However, in vitro the 
enzyme can also transfer a truncated substrate, a dolichyl 
diphosphoryl chitobiosyl unit (Figure 2-1) (5). 
~
OH 





Figure 2-1 Truncated oligosaccharide donor, Dol-P-P-GlcNAc2. 
Table 2-1 summarizes the specificity of the transferase towards a 
variety of oligosaccharyl donors. The "natural substrate" [Dol-P-P-
G1cN AC2Man9G1q], the disaccharide [Dol-P-P-G1cNAc2], and the 
trisaccharide [Dol-P-P-G1cNAc2Man] are similarly good substrates. 
The nonglucosylated lipid-linked oligosaccharide [Dol-P-P-
GlcNAc2Man9] and the monosaccharide [Dol-P-P-GlcNAc] are not 
substrates. 
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T bl 21 D a e - T' onor speCl IClt 0 f r o IJl;osacchar I transferase. 
substrate cpm/min % transfer 
Dol-P -P -G leN AC2Man9G lC3 2667 33.3 
Dol-P-P-GlcNAc2Man9 51 0.6 
Dol-P-P-GleNAc2Man 2415 30.1 
Dol-P-P-GleNAc2 2089 26.1 
Dol-P-P-GleNAc 94 1.2 
The transfer of radIOactivity from the vanous donors (8000 cpm/min 
corresponding to 100%) was measured after 15 min incubation. 
The observation that the enzyme does not transfer the 
nonglucosylated large lipid-linked oligosaccharide [Dol-P-P-
GlcNAc2Man9] suggests that the terminal glucoses have an important 
role in binding. Curiously shorter oligosaccharides regain substrate 
behavior. It has been suggested that the terminal glucoses serve to 
induce a conformational change in the enzyme which increases 
affinity for the peptide substrate. Nonetheless, oligosaccharyl 
transferase seems to exhibit a rather broad specificity with respect 
to the lipid-linked oligosaccharide. Since the truncated donor is 
easier to synthesize, efforts were directed to securing a supply for 
use in future transferase studies. 
The truncated donor can be biosynthesized in vitro by the 
action of two microsomal enzymes which sequentially transfer N-
acetylglucosaminyl phosphate (Enzyme I) and GlcNAc (Enzyme II) to 
dolichyl phosphate (Figure 2-2). However utilization of this method 
for large scale preparation of radiolabeled oligosaccharide donor is 
costly as well as problematic due to the lack of a cheap source of 
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dolichol phosphate and due to product inhibition of Enzyme I by 
uridine monophosphate (UMP). 
Dol-P + UDP-GIcNAc --=E=n;::z:..y..:::m::.:e:.......;;I:......_ Dol-P-P-GIcNAc + UMP 
Dol-P-P-GIcNAc + UDP-GIcNAc Enzyme II _=::...L:.=~:""._ Dol-P-P-GIcNAc2 + UDP 
Figure 2-2 Biosynthesis of the truncated oligosaccharide donor. 
Two important developments have provided a more reliable 
supply of the truncated oligosaccharide donor. The first was the total 
synthesis of dolichol phosphate from plant polyprenols isolated from 
the leaves of the Ginkgo biloba tree (8). Synthetic dolichol phosphate 
produced in this manner was shown to have identical biological 
activity to the compound isolated from liver (available from Sigma, 5 
mgs costing $217) and was of higher purity as determined by both 
tH NMR and TLC. 
The second development was the efficient synthesis of the 
radiolabeled truncated donor as described by Imperiali and 




















Figure 2-3 Synthesis of the truncated oligosaccharide donor. 
To facilitate incorporation of N -acetylglucosaminyl phosphate, Dol-P-
P-GlcNAc is chemically synthesized . Dolichol phosphate is first 
activated as the dichloroderivative. This produces a highly reactive 
species which can participate in a coupling reaction with per-O-
acetyl-N-acetyl glucosaminyl phosphate. The 
dolichylpyrophosphoryl ester can subsequently be O-deacetylated 
with 3% anhydrous sodium methoxide. This monosaccharide 
derivative can be converted into the corresponding disaccharide 
derivative by reaction with UDP-GlcNAc (radiolabeled at C-6 with 3H) 
in the presence of fresh porcine liver micro somes (described in detail 
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in the experimental section) . Incorporation of the radiolabel 
typically proceeds in about 25-30%. 
The sugar composition of purified lipid product has been 
verified by gel filtration. Purification was carried out by eluting 
diphosphoryl lipid compounds off DEAE-cellulose (acetate form) with 
20 mM ammonium acetate. This eluent was concentrated and 
reapplied to a silica column to separate unreacted Dol-P-P-GlcNAc 
from Dol-P-P-G1cNAc2. The purified product was characterized by 
acid catalyzed hydrolysis followed by gel filtration on a Biogel P-2 
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Determination of the oligosaccharide compOSItIOn of 
hydrolyzed Dol-P-P-GlcNAc-[3H]GlcNAc prepared as 
outlined above. 
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This synthetic method can easily produce as much as 20 ~Ci of Dol-P-
P-GlcNAc-[3H1GlcNAc, which represents an ample supply for 
extensive studies of the transferase. 
This facile route to an exogenous supply of the truncated 
oligosaccharide donor eliminated some of the common problems that 
were associated with earlier attempts to study oligosaccharyl 
transferase activity. First, it allowed the concentration of the donor 
to be varied at constant enzyme concentration. This allowed the 
determination of the optimal oligosaccharide substrate concentration 
which maximized the transfer reaction. More importantly, it allowed 
the assay to be performed at this optimal substrate concentration, 
thus ensuring that transfer would be observed if it occurred. 
Additionally, the ability to manipulate the chemical structure of the 
oligosaccharide donor led to insights into the transferase's specificity 
towards this substrate (10). 
This accessible supply of oligosaccharide donor also became the 
cornerstone of a convenient, inexpensive, and sensitive assay for 
oligosaccharyl transferase activity. This assay is described in detail 
later, but briefly it involves transfer of the radiolabeled truncated 
oligosaccharide donor to synthetic peptides using microsomes 
isolated from porcine liver as a source of the transferase. 
Earlier assay attempts were limited by the amount of 
radiolabel which could be incorporated into the oligosaccharide donor 
and subsequently tranferred to the peptidyl acceptor. However, 
some significant attributes of the transferase were ascertained. 
Work with synthetic peptides revealed that viable peptidyl acceptors 
must include the marker sequence, -Asn-Xaa-Thr/Ser-, and that the 
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amino group of the asparagine and the carboxyl group of the 
hydroxy amino acid residue must be blocked, either by incorporation 
of another amino acid or by chemical derivatization (3). The 
deleterious effect of leaving the termini free might be caused by 
either an unfavorable charge interaction at the active site of the 
enzyme or by the disruption of the recognized conformation of the 
peptide by formation of a salt bridge. 
Further it was demonstrated that the effect of the blocking 
groups is significant (11). The affinity of the peptidyl acceptor 
increases as the polypeptide backbone extends. Hydrophobic 
substituents also increase the efficiency of the peptide as a substrate. 
A role for hydrophobicity is consistent with the biology of the 
process of glycosylation. In vivo, nascent polypeptides attached to 
membrane bound ribosomes are glycosylated by the membrane-
bound transferase. Glycosylation is believed to occur at or near the 
luminal face of the ER while the protein is passing through the 
membrane on its way into the lumen. Thus the more a peptide 
associates with the membrane fraction used in the assay, the better 
it will interact with the transferase. This is confirmed in assays 
performed on large polypeptidyl acceptors (41 amino acids). The 
concentration of nonionic detergent had to be increased suggesting 
that only peptides which freely associate with the enzyme can be 
glycosylated, which is consistent with the increase in acceptor 
properties observed as hydrophobicity was increased. 
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EXPERIMENTAL METIIODS 
2.1 Preparation of crude membrane fraction from porcine liver 
Crude microsomal fractions were isolated from porcine liver as 
described by Zimmerman (10). This preparation was based on a 
procedure described by Behrens and Tabora (12). 
Materials: 
Homogenizing buffer 
50 mM Tris-HCI, pH 7.2 
0.25 mM sucrose 
2.5 mM MgCl2 




Fresh pig liver (l00 g) is cut into small pieces and blended with 
100 mL cold homogenizing buffer. The mixture is pulse-blended at 
4°C on high speed until no large lumps are present. The mixture is 
then centrifuged at 11,000 rpm in a Beckman type 16 rotor for 30 
minutes at 4°C in 250 mL centrifugation tubes. The supernatant is 
decanted into 25 mL tubes and centrifuged for another 30 minutes 
under the same conditions. The supernatant of this spin is 
centifuged at 25,000 rpm in a Beckman type 28 rotor for 1.5 hours at 
4°C. The pellet of this spin, containing the microsomal fraction , is 
mixed with glycerol to form a 30% glycerol mixture and stored at 
-80°C. This procedure typically affords 2.5-5 mL of a microsomal 
preparation (-100 mg/mL protein). This material can be stored for 
several months without significant loss of transferase activity. 
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2.2.1 Enzymatic synthesis of DOI-P-P-G1cNAc-[3H1GlcNAc 
Dol-P-P-G1cNAc-£3H]GlcNAc was enzymatically synthesized 
from synthetic Dol-P-P-GlcNAc as described by Imperiali and 
Zimmerman (8). 
Materials: 
Dol-P-P-GlcNAc (6 mg/mL in 3/2 chloroform/methanol) 
UDP_[3H]GlcNAc 
Homogenizing buffer (refer to 2.1) 
Nonidet P-40 (10% in Homogenizing buffer) 
neat microsomes (prepared in 2.1) 
4 mM MgCl2 
TUP (no salt) (12/192/186 chloroform/methanol/water) 
Procedure: 
Dol-P-P-GlcNAc (5 A) was added to an Eppendorf tube along 
with 1.5 IlCi UDP_[3H]GlcNAc. This mixture was dried under a gentle 
stream of nitrogen. Nonidet P-40 (10% solution, 10 A) and 85 A 
Homogenizing buffer were added consecutively with vortexing after 
each addition. Neat microsomes (5 A) were added to initiate the 
reaction. The Eppendorf was gently agitated on an orbital shaker for 
30 minutes after which time the reaction was quenched with 1.0 mL 
3/2 chloroform/methanol and 0.2 mL 4 mM MgC12. The Eppendorf 
was vortexed to thoroughly mix the reaction mixture with the 
quench solution. This mixture was centrifuged at 6,000 rpm for 2 
minutes in a microcentrifuge to promote phase separation. The 
resulting mixture separated into an organic lower phase, an aqueous 
upper phase, and a proteinaceous interphase. The upper phase was 
removed. The proteinaceous interphase and the lower phase were 
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washed with 0.6 mL TUP (no salt). After a second centrifugation, the 
upper phase was combined with the previously isolated upper phase. 
The lower phase was removed from the proteinaceous pellet. The 
pellet was sonicated in 0.5 mL 3/2 chloroform/methanol for 5 
minutes. The solution was decanted away from the pellet and 
combined with the previously isolated lower phase. The lower phase 
was blown down, resuspended in a known volume of 3/2 
chloroform/methanol, and counted for radioactivity. A typical 
experiment consisting of 20 Eppendorfs yielded around 9,000,000 
dpm of crude Dol-P-P-GlcNAc-[3HJGlcNAc (_30% conversion). 
The crude product was purified on silica gel G. Unreacted Dol-
P-P-GlcNAc was eluted with 72/21/2 chloroform/methanol/water 
and the product, Dol-P-P-GlcNAc-[3HJGlcNAc, with 60/25/4 
chloroform/methanol/water. 
2.2.2 Detergent effect (enzyme II) 
The efficiency of various detergents used to solubize the Dol-P-
P-GlcNAc with the membrane was examined. The microsomal 
fraction was dissolved in 85 A. Homogenizing buffer and 10 A. of 
either 10% Nonidet P-40 or 10% Triton X-loo was added. The 
mixture was gently agitated on an orbital shaker for 30 min. The 
reaction solution was quenched and worked up as described above. 
The percent conversion was determined by comparing the fraction of 
radioactivity present in the organic layer (Dol-P-P-GlcNAc-
[3HJGlcNAc) with that present in the aqueous layer (unreacted UDP-
[3H]GlcNAc). 
39 
Table 2-2 Efficiency of various detergents in solubilizing Dol-P-P-
G1cNAc 
Detergent aqueous organic total % conversion 
Triton X-loo 720000 79000 799000 9.9 
Nonidet P-40 692000 135000 827000 16.3 
The results are summarized in Table 2-2. Nonidet P-40 shows 
increased efficiency in solubilizing the lipid-linked oligosaccharide 
and therefore was used in all further experiments. 
2.2.3 MgOI) requirement (enzyme II) 
Incubations with UDP-[3HjG1cNAc were carried out according to 
standard assay conditions with varying concentrations of MgCI2 . The 
reaction shows an essential requirement for Mg2+ ions. Divalent 
cations have previously been shown to stimulate the activity of 
enzyme II in microsomes isolated from yeast (13). 
Table 2-3 Effect of Mg(II) on the activity of enzyme II 
conc. MgCl2 aqueous organic total % conversion 
OmM 756000 500 756500 0.07 
2.5 mM 600000 139000 739000 18.8 
IOmM 720000 79000 799000 9.9 
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2.3.1 Qli~osaccharyl transferase assay- Isolation of ~lycopeptide 
Materials: 
Dol-PP-GlcNAc-[3H1GIcNAc, 50,000-200,000 dpm 
Assay buffer: 
50 mM Tris-HCI, pH 7.5 
10 mM MnCi2 
1.2% Triton X-lOO 
Micromix: 
200 ).. crude microsomes 
1400 ).. assay buffer 
peptide in DMSQ 
TUP with salt (12/192/186/2.69 
chloroform/methanol/water/0.25 M MgCI2) 
Procedure : 
Typically, 200,000 dpm Dol-PP-GlcNAc-[3H1GIcNAc was 
aliquoted into 1.8 mL Eppendorf tubes and dried under a gentle 
stream of nitrogen. Peptide solution (10 )..) was added to each 
Eppendorf and vortexed to dissolve glycolipid. Assay buffer (40 
)..) was added and again vortexed. At 0 minutes,150 ).. Micromix 
was added to each Eppendorf and vortexed to ensure thorough 
mixing. The assay was shaken at room temperature on an orbital 
shaker during which four 40)" aliquots of the reaction mixture 
were removed and quenched into 7 mL scintillation vials 
containing 1.2 mL 3/2/1 chloroform/methanol/4 mM MgCI2 . 
The quenched reaction aliquots were treated as follows to 
isolate the glycopeptide product away from the unreacted lipid-
linked donor. The upper aqueous phases of the quenched 
solutions were removed into 7 mL scintillation vials. The lower 
phase (organic phase and proteinaceous pellet) was reextracted 
twice with 0.8 mL TUP w/salt. The upper phases were combined 
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and back extracted with 0.2 mL chloroform. The chloroform was 
pooled with the lower phase which was left overnight to dry. 
The upper aqueous phase was dissolved into about 6 mL 
Ecolite (leN) and the amount of tritium was quantitated as 
disintegrations per minute (dpm). The transfer of tritium into this 
aqueous phase represents the amount of newly formed 
glycopeptide. 
The organic phase was redissolved in 0.2 mL Solvable 
(DuPont) . After shaking for 2-3 hours, 6 mL Formula 989 
(DuPont) was added and the amount of tritium was quantitated. 
The tritium remaining in this phase represents the amount of 
unreacted glycolipid. The data was normalized for each 
Eppendorf. 
The observed rates were shown to be due to enzyme-
catalyzed glycosylation, and not due to hydrolysis of the lipid-
linked substrate to afford a water soluble disaccharide, by the 
following experiments. First, reactions in the presence of all 
standard assay constituents initiated with thermally denatured 
microsomes showed no discernable substrate hydrolysis. 
Secondly, water soluble radioactive material, obtained from the 
assay, was prepared on a large scale and subjected to acid 
catalyzed hydrolysis followed by gel filtration analysis on a Biogel 
P-2 column (eluent 50 mM acetic acid). The major radioactive 
material eluted corresponded to a compound with higher 
molecular weight than di-N-acetylchitobiose which is consistent 
with formation of glycoprotein. 
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2 .3.2 Glycerol dependence (olieosaccharyl transferase) 
Bz-NLT-NMe (0.5 mM) was incubated with Dol-P-P-GlcNAc-
[3H]GlcNAc according to standard assay conditions except the 
amount of assay buffer contained in the micro mix was varied. As 
more assay buffer was added the effective concentration of both 
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Figure 2-5 Glycerol dependence of oligosaccharyl transferase. 
Figure 2-5 demonstrates that as the concentration of glycerol in 
the assay was decreased the transfer velocity increased. The 
velocity differences observed are even more striking considering 
that the effective enzyme concentration also decreased. Glycerol 
is necessary to maximize the time which the liver can be stored at 
-85°C (10). 
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2.3.3 DMSO dependence (oli~wsaccharyl transferase) 
Bz-NLT-NMe (0.5 rnM) was incubated with Dol-P-P-GIcNAc-
[3H]GlcNAc according to standard assay conditions except the 
percentage of DMSO was varied. 
400 r c 'JI DMSO • dpm min· 1 
5 344 
c 10 396 
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Figure 2-6 DMSO dependence of oligosaccharyl transferase. 
Figure 2-6 illustrates that increasing the percentage of DMSO appears 
to subtly increase the transfer velocity up to 15% after which the 
velocity drops off. The optimum percentage of DMSO in the 
transferase assay is around 10%. This finding contradicts an earlier 
report (14) which found that the addition of DMSO had no 
observable effect on the transferase properties of tripeptides. 
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The addition of DMSO to the enzyme assay probably has two 
effects. DMSO has previously been shown by circular dichroism 
experiments to increase the amount of secondary structure in 
peptides containing at least five residues (14). Thus, DMSO may 
increase the population of the conformation which is recognized by 
the enzyme. The second effect might be to solubilize the membrane-
bound enzyme and the oligosaccharide donor, or alternatively to 
mimic the membrane interface where glycosylation occurs. 
2.3.3 Effect of Blocking Groups 
Table 2-4 summarizes the substrate behavior for five peptides 
which are composed of the marker sequence blocked with various 
groups. The glycosyl acceptor properties were determined with Dol-
P-P-GlcNAc-[3HlGIcNAc using standard assay conditions. The data 
were obtained with oligosaccharide donor of identical specific 
radioactivity and are thus directly comparable. Km and Vmax values 
were determined for each of the peptides as well as a relative 
acceptor activity value (the plots used to determine these values are 
included in Appendices 2-1 to 2-5). 
Table 2-4 Relative acceptor activities for the glycosylation of 
bl k d ·d oc e tnpeptl es. 
peptide Km (mM) V max (dpm min-I) VmaxJKm 
Boc-NLT-OMe 1.13 186 164.6 
Ac-NLT-OMe 2.68 500 186.6 
Ac-NLT-NHMe 0.56 431 769.6 
Bz-NLT-OMe 0.54 1550 2870.4 
Bz-NLT-NHMe 0.47 4208 8953.2 
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Bz-NLT-NHMe was the best glycosyl acceptor in this study, 
as determined by its highest Vmax/Km value. Substitution of the 
N-terminal benzoyl group with an acetyl group decreased the 
relative rate 10-15 fold. Substitution of the C-terminal methyl 
ester with a methyl amide increased the relative rate 3-4 fold. 
The effect of the various blocking groups on the rate of 
glycosyl transfer is best understood in terms of the topology of 
the process. The polypeptide acceptor which interacts with the 
transferase is still being translated through the ER membrane. 
Thus, the enzyme active site is likely equipped to recognize a 
marker sequence which is attached via an amide bond to the 
remaining portion of the polypeptide. An amide at the C-terminus 
more accurately mimics the normal substrate than a methyl ester. 
Furthermore, if this amide proton is involved in a hydrogen 
bonding interaction with the enzyme, the loss of this proton would 
lower the binding efficiency of the peptide. Also the lipid linked 
oligosaccharide donor and the transferase are both attached to 
the hydrophobic ER membrane. As the hydrophobicity of the 
terminal blocking groups increases, the ability of the peptide to 
interact with the membrane increases and glycosylation is 
promoted. 
CONCLUSIONS 
Small peptides containing the marker sequence, -Asn-Xaa-
Thr/Ser-, and blocked at the carboxyl and amino termini can be 
glycosylated in vitro by a microsomal fraction isolated from 
porcine liver. The glycosyl acceptor abilities of these peptides can 
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be reliably determined by monitoring the transfer of radiolabelled 
oliosaccharide from semi-synthetically prepared Dol-P-P-GlcNAc-






2-1 Enzyme kinetic data for Boc-NLT-OMe. 
dpm/min Boc-NLT-OMe 
-e-l0mM --y - 2418 + 168.48x R_ 0 .94288 
-ft-2.5mM --Y - 1219.5 + 12O.93x R_ 0.00.24 
--6-1.25mM --y _ 1939 + 92.175x R_ 0.93734 
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Appendix 2-2 Enzyme kinetic data for Ac-NLT-OMe 
dpm/min Ac·NLT·OMe 
~10mM --y. 6465 + 412.25x R. 0.99685 
--5 mM -- Y • 3289 + 287.34x R. 0.99778 
---..0- 2.5 mM -- y • 3349.4 + 23O.92x R. 0.99958 
-+-1 mM --Y • 3303.4 + 106.62x R. 0.99969 
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Appendix 2-3 Enzyme kinetic data for Bz-NLT-OMe 
dpm/min Bz-NLT-OMe 
----e--5mM --y _ 1710.2 +. 1319.5x R- 0.99974 
-><-2.5mM --y _ 2828.7 + 1745.6. R_ 0 .99297 
-- 1 mM --y _ 4679 + 856.36. R_ 0.98695 
-+-0.5mM --y _ 3042 + 631 .38. R_ 0.99415 
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~5mM --y _ 12428 + 402.05. R_ 0.99292 
__ 2.5mM --y _ 10448 + 315.96. R_ 0.97432 
-.>-1 mM --y _ 10098 + 229.82. R_ 0.49716 
__ 0.5 mM -- Y _ 4378 + 244.28. R_ 0.98923 
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~O --y _ 2105 + 207.3x R_ 0.61273 
--0.05 --Y _ 1828.3 + 405.81 x R- 0.99683 
-""'-0.1 --y _ 2429.7 + 715." R- 0.9936 
-+-- 0.2 -- Y - 2410 .9 + 1255.8x R_ 0 .99346 
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Molecular Modelling and 
Amide Exchange Experiments on Hexapeptides 
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On the basis of structural analysis of a number of known N-
glycosylated proteins, Marshall suggested that the marker sequence, 
-Asn-Xaa-Thr/Ser-, is a necessary requirement for glycosylation (1). 
However, since not all such sequences in proteins become 
glycosylated this marker sequence is evidently not the only 
prerequisite. It is well established that glycosylation is blocked 
when the central residue of the marker sequence, Xaa, is proline (2) , 
but this rule accounts for only a minor portion of all known non-
glycosylated marker sequences. 
Several researchers have attempted to unravel the other 
requirements necessary for glycosylation. Gavel and von Heijne have 
done a thorough statistical analysis of known N-glycosylated proteins 
(3). They looked for correlations between the glycosylation tendency 
of marker sequences and the position of these sequences within the 
protein. They found that the frequency of non-glycosylated sites 
was higher towards the C-terminus of most proteins and also when 
the site contained proline as either the central residue or the residue 
flanking the hydroxy amino acid. They postulated that local 
conformation within and surrounding the marker sequence 
influences glycosylation. Beyond this, they concluded that there 
were no local patterns, other than the marker sequence, within the 
primary amino acid code which correlated with glycosylation. 
Their results further substantiated Van Rietschoten's finding 
that Ac-Asn-Ala-Thr-NH2 was the smallest peptide to be 
glycosylated in vitro (4). The fact that this tripeptide is recognized 
by the enzyme indicates that all the necessary structural features 
required for binding are present within the molecule. Thus although 
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both the overall folding of the protein as well as the local 
conformation surrounding the marker sequence may affect 
glycosylation, a tripeptide sequence with blocked termini is 
sufficient. 
The complete tripeptide marker sequence was confirmed to be 
required for glycosylation by Hart et al. (5). They showed that a 
dipeptide containing only the first two residues of the marker 
sequence could not be glycosylated in vitro (Table 3-1). Ac-Asn-
Gly-Ser-NHMe was a good acceptor, but Ac-Asn-Gly-NHMe is 
inactive, clearly indicating that the tripeptidyl marker sequence is 
the minimal encoded structure necessary for recognition by the 
enzyme. 
Table 3-1 Relative acceptor activItIes for the glycosylation of 
peptides by hen oviduct microsomes. Activity is 
expresse d l ' GNLSL re atIve to 
Relative acceptor activity/nmol 
Peptide of peptide 
GNLSL 1 
Ac-NGS-NHMe 0 .7 
Ac-NGS-OMe 0.2 
Ac-NG-NHMe <0.01 
The significance of the third residue, the hydroxy amino acid, 
in the marker sequnce has been extensively questioned . Since its 
presence within the marker sequence is a strict requirement, 
Marshall postulated that it must be somehow involved in inducing a 
very specific conformation within the peptide which can be 
recognized by the enzyme. Marshall proposed that a hydrogen bond 
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formed between the hydroxyl group of the hydroxy amino acid and 
the carboxyamido group of the asparagine might form a unique 
structure within the peptide which the enzyme might then recognize 
(Figure 3-1) (1). 
Figure 3-1 Hydrogen bonding array proposed by Marshall. 
The role of the hydroxy amino acid in the marker sequence 
was investigated (6) by using a series of hexapeptides derived from 
Tyr-Asn-Gly-Xaa-Ser-Val by substituting threonine, serine, cysteine, 
valine and O-methylthreonine for Xaa (Table 3-2). 
Table 3-2 Glycosyl-acceptor activity of hexapeptides contammg 
modifications of the hydroxyl amino acid within the 
marker sequence. Relative transferase activity 
(Vmax/Km) was based on the activity of the serine-
'd con taming peptl e. 
Relative 
Peptide Km (mM) Vmax transferase 
(cpm/lO min) activity 
YNGTSV 0.16 2080 40 
YNGSSV 1.6 550 1 
YNGCSV - - 0.4 
YNGVSV - - 0 
YNGT(OMe)SV - - 0 
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These results show that serine, threonine, and cysteine-containing 
peptides were glycosylated, although at very different rates, whereas 
valine and O-methylthreonine containing peptides were not 
substrates. Replacement of threonine by serine resulted in a four 
fold decrease in V max and about a ten fold increase in Km for 
oligosaccharyl transferase. Replacement of serine by cysteine again 
decreased acceptor activity two to three fold. These results indicate 
an absolute requirement for a hydrogen bond donor function in the 
side chain of the hydroxyl amino acid of the marker sequence and 
furthermore, point to a considerable influence of this amino acid in 
binding as well as in turnover. In order to include the observed role 
of the hydroxyl group as a hydrogen bond donor and at the same 
time rationalize the substrate behavior exhibited by this series, 
Bause and Legler proposed an alternate model which contained a 
hydrogen bond interaction between the side chain amide of 
asparagine (the proton donor) and the oxygen of the hydroxyl group 
of the hydroxyl amino acid (the proton acceptor) (Figure 3-2) (6). 
The rationale behind their mechanism will be examined in more 
detail in chapter 6. 
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Figure 3-2 Bause and Legler's proposed hydrogen bond array. 
The conformations of several tripeptide substrates have 
previously been examined using energy calculations (7). These 
studies suggested that despite their diminished size, these 
peptides exhibit a high probability for secondary structure 
formation. However these studies were limited by a lack of 
experimental support. 
Our initial approach to exploring the possibility that a 
specific conformation within the peptide was being recognized by 
the enzyme included both computational modelling and ID NMR 
experiments. 
EXPERIMENTAL ME1HODS 
3.1 Computational Modellint: 
The computational study described below was done in 
collaboration with C. L. Brooks at Carnegie Mellon University. The 
modelling program CHARMM (8) was used to perform molecular 
dynamic studies on a series of hexapeptides in an attempt to 
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correlate peptide conformation to substrate behavior in 
glycosylation. The copy of the CHARMM program which was used 
was under development and had been supplied by Prof. M. Karplus. 
Computations were performed on a V AX computer and structural 
data was analyzed with the aid of an Evans and Sutherland Graphics 
system. 
Three hexapeptides were examined: Ac-PNGTA V -NH2, Ac-
ANGTAV-NH2, and Ac-YNPTSV-NH2. These peptides were chosen 
because the substrate behavior of their unblocked counterparts had 
previously been determined (Table 3-3) (9). Of these peptides, 
PNGT A V and ANGT A V exhibit substrate behavior. The slightly 
better substrate behavior exhibited by PNGTAV has been attributed 
to an increased population of the recognized conformer produced by 
the presence of the constrained imino acid. 
Table 3-3 Glycosyl acceptor properties of hexapeptides containing 
r . h· d d · h k e. pro me Wit 10 an surroun 109 t e mar er sequenc 
Peptide Vmax/Km Ki (mM) 
(H2N+)PNGTAV(COO-) 0.51 -
(H~N+)ANGTAV(COO-) 2.6 -
(H3N+)YNPTSV(COO-) - >5 
CHARMM was used to construct the hexapeptide structures, to 
energy minimize them using first and second derivative techniques, 
to perform dynamic simulations, and to analyze the structural and 
dynamic properties determine by these calculations. The study was 
aimed at finding a representative sampling of minimum energy 
structures for each hexapeptide. The compounds were studied as 
blocked hexapeptides to prevent electrostatic interactions from 
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dominating the energy studies . In order to obtain the most accurate 
sampling, the Monte Carlo approach known as simulated annealing 
(10) was used during the dynamics simulation. This approach 
efficiently finds the global energy minima along the potential energy 
surface. It differs from conventional iterative minimization because 
it allows molecules to escape local minima as the temperature is 
decreased. 
3.1.1 Generation and Minimization of Structures 
Each structure was treated as an isolated molecule in a vacuum. 
The structures were generated using CHARMM's protein topology and 
parameter files. Each structure was initially minimized with an NOE 
constraint between the side chain amide nitrogen of the asparagine 
and the hydroxyl oxygen of the threonine. The constraint was used 
to keep these atoms within hydrogen bonding distance (3.0 A). This 
constraint was used since it was proposed that this was the 
important interaction necessary for binding (10). The structures 
were minimized using adopted-basis set Newton-Raphson 
minimization (8). The NOE constraint was gradually reduced to zero 
as the energy was minimized. The final minimized structures were 
then used in molecular dynamic simulations. 
An example of a CHARMM Input File used to generate the 
initial minimized structure for Ac-PNGTA V -NH2 is included in the 
Appendix 3-1. 
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3.1.2 Dynamics simulations 
A simulated annealing strategy was adapted into the CHARMM 
program and employed during the dynamics simulation. First the 
minimized structure was heated to 598 Kover 10 picoseconds, the 
temperature was maintained at 598 K for 5 picoseconds, the 
temperature was then lowered back to 298 Kover 10 picoseconds, 
and finally 10 picoseconds of dynamics were performed (Figure 3-3). 
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Figure 3-3 Timeline of simulated annealing experiment 
continually minimized. During the final 10 picoseconds of the 
simulation a dynamic trajectory was generated and at 10- 2 
picosecond intervals, snapshots of this trajectories were stored for 
later analysis. 
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The dynamics runs were carried out at a dielectric constant of 
ten. This dielectric value had been previously shown (11) to be 
optimal for observing folding of a peptide during a 20 picosecond 
simulation. Dielectric values above ten produced structures which 
did not fold during the simulation, while values below ten produced 
structures with abnormally high amounts of hydrogen bonding. An 
example of a CHARMM input file used to generate the dynamic 
trajectory for Ac-PNGTA V -NH2 is included in Appendix 3-2. 
Six different dihedral angles were followed over the course of 
each dynamic simulation. These are illustrated in Figure 3-4. 
Figure 3-4 Dihedral angles measured during simulated dynamics. 
The probability of each dihedral angle, -180° to 180°, was 
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Figure 3-5 Ramachandran plots of the lowest energy conformers of 
Ac-PNGTAV-NHz. Ac-ANGTAV-NHZ. and Ac-YNPTSV-












Four different hydrogen bond distances (Figure 3-6) were also 
followed during the simulation. 
Figure 3-6 Bond distances measured during simulated dynamics. 
RESULTS AND DISCUSSION 
Ramachandran plots of the cP, 'P dihedral angles obtained from 
the dynamic trajectory are shown in Figure 3-5. The three dihedrals 
shown define the conformation of the marker sequence within each 
of three peptides examined. The only correlations between structure 
and substrate behavior which are evident are that substrates must 
be able to access the following average dihedral angles: cP2, =-90, 'P 2 
= -45; cP3 = -80, 'P 3= -45; and cP4 = -90, 'P 4 = 120. When these values 
are used to regenerate a structure, a polypeptide with an extended 
backbone is produced. In comparison, the backbone of the 
non substrate, Ac-YNPTSV -NH2, cannot fully extend and is instead 
kinked due to the restriction around the cP, 'P dihedral angles of 
proline. This data suggests that the enzyme requires a rather 
extended backbone within the peptide acceptor for binding. Thus, 
specific backbone dihedral information cannot be derived from these 
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studies; however, based on bond distance information a dominant 
conformation does appear to exist. 
Significantly, structural data obtained from bond distance 
analysis correlates with substrate behavior. There seems to be a 
high probability in the substrate peptides for formation of a 
hydrogen bond between the side chain carbonyl oxygen of 
asparagine and the backbone amide of threonine (refer to Figure 3-5, 
bond 1). This bond distance is routinely 2-4 A. A second hydrogen 
bonding interaction between the same carbonyl oxygen and the 
hydroxyl group occurs to a lesser extent (Figure 3-5, bond 2). In 
Figure 3-7 the distances of each putative hydrogen bond followed 
during the simulation of Ac-PNGTA V -NH2 is plotted as a 
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Figure 3-7 Percent distribution of bond distances within the lowest 
energy conformers of Ac-PNGT A V -NH2. 
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The structures superimposed above these plots are representative of 
the conformations observed during the simulation. In Figure 3-8 
bonds 1 and 2 are compared for all three peptides. The average 
distance for both of these bonds decreases dramatically down the 
series and correlates well with the observed substrate behavior for 
these peptides. Thus, hydrogen bond formation between the side 
chain carbonyl oxygen of asparagine and the backbone amide of 
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Figure 3-8 Distribution of bond distances observed for bonds 1 
and 2 within the lowest energy conformers of Ac-
PNGTAV-NH2 and Ac-ANGTAV-NH2. Bond distances 
lengthen as substrate behavior decreases. 
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EXPERIMENTAL METIIODS 
3:2 Analysis of Peptide Conformation by lH NMR 
It is generally recognized that the rates of exchange of 
deuterium for hydrogen in proteins reflects the structure and 
conformation of these molecules (12). However, unraveling the 
contributions of structure to hydrogen exchange behavior requires 
knowledge of the micro environment surrounding each proton in the 
unstructured polypeptide. A variety of factors influence the primary 
hydrogen exchange rate of a proton within a polypeptide: 
hydrophobic groups, charge interactions, general acid base catalysis 
by side chains, and inductive effects which can alter local water 
chemistry. It has been shown that in polypeptides, the exchange 
rate of a given backbone amide proton is predominantly influenced 
by nearest-neighbor substituents and that these influences can be 
accurately represented by summing the individual effects of each 
adjacent amino acid. Furthermore, the influence of each of the 20 
naturally occurring amino acids has been determined in model 
studies (13). 
Using this information, it was possible to predict the relative 
exchange rate for each of the backbone ami des within the two 
peptidyl substrates, Ac-PNGTA V -NH2 and Ac-ANGTA V -NH2. If no 
secondary structure is present, the relative exchange rates of all of 
the amide protons are similiar (i.e., within the same order of 
magnitude). Therefore, any amide proton which had a relative 
exchange rate which was slower by one order of magnitude or more 
from the other amide protons was assumed to be solvent shielded. 
71 
3.2.1 Synthesis of Hexapeptides 
Ac-PNGTAV-NH2 and Ac-ANGTAV-NH2were synthesized via 
solid phase methods using a DuPont RAMPS semi-manual peptide 
synthesizer. Fmoc-amino acids were activated as OPfp esters and 
were coupled to RapidAmide resin (DuPont) in the presence of HOBT. 
Subsequent amino acids were also activated as Fmoc-AA-OPfp esters 
and coupled in the presence of HOBT. The coupling steps were 
monitored for completeness using the Kaiser test. The Fmoc group 
was deprotected with 50% piperidine/DMF. After chain extension 
was completed, the N-terminus was deprotected as before and 
capped with acetic anhydride while the peptide was still attached to 
the resin. The resin was simultaneously side-chain deprotected and 
cleaved from the resin using TFA to yield crude product. This crude 
residue was purified by trituration from methanol with 111 
Et20/Hexane. 
PHYSICAL DATA 
Ac-PNGTA V -NH2 
lH NMR (d6-DMSO) 0: 0.75 (6H, m); 1.0 (3H, d); 1.2 (d, 3H); 1.3 
(lH, m); 1.8 (7H, m); 2.5 (2H, m); 3.4 (2H, m); 3.8 (2H, m); 4.0 (2H, 
m); 4.1 (lH, m); 4.2 (lH, m); 4.4 (IH, q); 4.6 (lH, q); 6.9 (lH, s); 7.0 
(lH, s); 7.3 (lH, s); 7.4 (IH, s); 7.6 (lH, t); 7.7 (lH, d); 7.9 (lH, d); 
8.2 (lH, d); 8.3 (lH, d). 
Ac-ANGTAV-NH2 
lH NMR (d6-DMSO) 0: 0.75 (6H, m); 1.0 (3H, d); 1.3 (6H, m); 1.8 (3H, 
s); 1.9 (lH, m); 2.5 (2H, m); 3.7 (2H, d); 3.9 (lH, m); 4.0 (lH, m); 4.2 
(3H, m), 4.5 (lH, m); 4.9 (lH, d); 6.9 (lH, s); 7.0 (lH, s); 7.3 (lH, s); 7.4 
(lH, s); 7.6 (IH, d); 7.7 (lH, d); 7.7 (lH, d); 7.9 (2H, m); 8.1 (lH, d); 8.2 
(lH, d). 
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3.2.2 ID Hydrogen Exchange Experiments 
Nuclear magnetic resonance spectra (lH) were recorded on a 
Bruker 300 MHz spectrophotometer. IH NMR shifts were reported in 
parts per million (ppm) downfield from tetramethylsilane as an 
internal standard on the Ii scale. Peak identification was determined 
by homonuclear decoupling experiments. 
First-order hydrogen-deuterium exchange rates were 
measured by transfer of deuterium from D20 to the peptide. The 
peptide was lyophilized from water (pH 4.0) and redissolved in 
enough d6-DMSO to yield a 20 mM solution. The exchange rates were 
measured at 25°C after the addition of 10% D20 to the DMSO sample. 
The NMR signal of the amide protons were recorded over time, 
integrated, and normalized to the <x-proton of the asparagine residue. 
RESULTS AND DISCUSSION 
The integral values of the amide proton peaks were plotted as 
a function of time where 0 minutes indicates the addition of D20 
(Figure 3-9). The exchange rate was assumed to be first order, thus 
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Figure 3-9 Amide proton exchange rates of Ac-ANGTA V -NH2. 
The profile for Ac-PNGTA V -NH2 is similar. 
The only proton in both peptides which exhibited a drastically 
reduced exchange rate was the threonine backbone amide. Thus this 
amide was concluded to be solvent shielded. 
CONQ..USIONS 
In order to obtain quantitative information from these 
experiments it would have been necessary to recalculate the 
observed exchange rate over a range of pH values. Several factors 
influenced the decision to seek alternate experiments to obtain 
structural information. The proton exchange experiment was highly 
sensitive to temperature, pH, and concentration. Thus, not only was 
the accumulation of data time-consuming, but the data obtained 
could only be compared on an individual basis . Since the research 
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was focused on correlating structure and function, it was necessary 
to find an alternate approach which would allow us to compare 
information within a series. 
The deciding factor was the upgrade in available NMR 
equipment which allowed us to aquire 2-D NMR data. Our approach 
thus switched to studying the secondary structural features present 
within the peptidyl acceptor using 2-D NOE experiments. 
Both the computational study and the amide exchange 
experiment indicated that the threonine backbone amide was solvent 
shielded. The modelling study suggested that there was a high 
probability in substrate peptides for formation of a hydrogen bond 
between the side chain carbonyl oxygen of asparagine and the 
backbone amide of threonine. Further experiments were necessary 
to clearly demonstrate whether this interaction was present. 
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Appendix 3-1 CHARMM input file used for minimization 
*MINIMIZA TION 
OPEN READ UNFORMATfED UNIT 1 NAME TOPHI9.MOD 
READ RTF UNIT 1 
CLOSE UNIT 1 
OPEN READ UNFORMATfED UNIT 2 NAME PARAMI9.MOD 
READ PARA UNIT 2 
CLOSE UNIT 2 
READ SEQUENCE CARD 
* Ac-PNGTAV-NH2 .. 
8 
ACE PRO ASN GL Y THR ALA VAL BLK 
GENERATE NGT SETUP 
IC PARAM 














MINI ABNR NSTEP 50 NPRINT 50 
IC FILL 
INCR 3 BY -0.5 
IF 3 GT 0.0 GOTO START 
RESET 
END 
MINI ABNR NSTEP 250 NPRINT 50 
IC FILL 
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OPEN UNIT 7 WRITE FORMATTED NAME PNGTA V.IC 
WRITE IC UNIT 7 
* INTERNAL COORDINATES 
* 
OPEN UNIT 8 WRITE FORMATTED NAME PNGTAV.CHR 
WRITE COOR CARD UNIT 8 
*X, Y,ZCOORDINATES 
* 
OPEN UNIT 9 WRITE FORMATTED NAME PNGTA V.ENG 





Appendix 3-2 CHARMM input file used for dynamics simulation 
"DYNAMICS-SIMULATED ANNEALING 
" 
OPEN READ UNFORMATTED UNIT I NAME TOPHI9.MOD 
READ RTF UNIT I 
CLOSE UNIT I 
OPEN READ UNFORMATTED UNIT 2 NAME PARAMI9.MOD 
READ PARA UNIT 2 
CLOSE UNIT 2 




ACE PRO ASN GL Y THR ALA VAL BLK 
GENERATE NGT SETUP 
OPEN UNIT 7 READ FORMATTED NAME PNGTA V.CHR 
READ COOR CARD UNIT 7 
CLOSE UNIT 7 
OPEN UNIT 8 WRITE UNFORM NAME DYN.COR 
OPEN UNIT 9 WRITE FORM NAME DYN.RES 
OPEN UNIT 10 WRITE FORM NAME DYN.CHR 
WRITE COOR CARD UNIT 10 
SHAKE BONH TOL 1.0E-7 
DYNA VERLET STRT NSTEP 10000 TIMESTEP 0.001 IUNCRD 10 NSA VC 10 TWINDH 
5.0 TWINDL -5.0 IASORS 0 IASVEL 1 ICHECW 1 IEQFRQ 0 IUNWRITE 11 FIRSTT 
298.0 FINALT 598.0 ISEED 2718 INBFRQ 0 CUTNB 11.5 CITONNB 9.5 CTOFNB 10.5 
EPSI 10.0 VDW NBXMOD 5 VSWITCH VDISTANCE 
OPEN UNIT 10 WRITE UNFORM NAME DYN.COOR 
OPEN UNIT II READ FORM NAME DYN.RES 
OPEN UNIT 13 WRITE FORM NAME DYN2.RES 
DYNA VERLET RESTART NSTEP 5000 TIMESTEP 0.001 IUNCRD 10 NSAVC 10 
TWINDH 5.0 TWINDL -5.0 IASORS 0 lAS VEL 1 ICHECW 1 IEQFRQ 0 IUNWRITE 13 
IUNREAD 11 FIRSTT 598.0 FINALT 598.0 ISEED 230259 INBFRQ 20 CUTNB 11 .5 
CITONNB 9.5 CTOFNB 10.5 BPSI 10.0 VDW NBXMOD 5 VSWITCH VDISTANCE 
OPEN UNIT 10 WRITE UNFORM NAME DYN.COOR 
OPEN UNIT II READ FORM NAME DYN2.RES 
OPEN UNIT 13 WRITE FORM NAME DYN3.RES 
DYNA VERLET RESTART NSTEP 10000 TIMESTEP 0.001 IUNCRD 10 NSAVC 10 
TWINDH 5.0 TWINDL -5.0 IASORS 0 IASVEL 1 ICHECW 1 IEQFRQ 0 IUNWRITE 13 
IUNREAD 11 FIRSTT 598.0 FINALT 298.0 ISEED 230259 INBFRQ 20 CUTNB 11.5 
CTTONNB 9.5 CTOFNB 10.5 BPSI 10.0 VDW NBXMOD 5 VSWITCH VDISTANCE 
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OPEN UNIT 10 WRITE UNFORM NAME DYN.COOR 
OPEN UNIT 11 READ FORM NAME DYN3.RES 
OPEN UNIT 13 WRITE FORM NAME DYN4.RES 
DYNA VERLET RESTART NSTEP 10000 TlMESTEP 0.001 IUNCRD 10 NSA VC 10 
TWINDH 5.0 TWINDL -5.0 IASORS 0 lAS VEL 1 ICHECW I IEQFRQ 0 IUNWRITE 11 
IUNREAD 13 FIRSTT 298.0 FINALT 298.0 ISEED 230259 INBFRQ 20 CUTNB 11.5 
CTTONNB 9.5 CTOFNB 10.5 EPSI 10.0 VDW NBXMOD 5 VSWITCH VDISTANCE 
OPEN UNIT 10 WRITE FORM NAME DYN.CRD 
WRITE COOR CARD UNIT 10 
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Kinetic and Structural Studies 
on Tripeptidyl Acceptors 
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The strict requirement of carbohydrate attachment at -Asn-
Xaa-Thr/Ser- sites suggests that the polypeptide acceptor should 
have a very specific conformation, at least temporarily, in order to be 
recognized at the active site of the transferase. Based upon studies 
with peptide derivatives which contained modifications of the 
hydroxy amino acid, it was established that this residue was 
required for catalytic activity (1). These studies further suggested 
that a hydrogen bond interaction between the side chain of the 
asparagine and the hydroxy amino acid existed. Consequently, it was 
proposed that peptidyl acceptors must be able to adopt a 
conformation that would position these side chains close together in 
space. 
Glycosyl transfer acceptor studies with synthetic peptides have 
been documented by Aubert et al. (2), Bause et al. (3), Aubry et al . 
(4) and Abbadi et al. (5). In addition, structural studies involving 
circular dichroism (2, 3a, 4), infrared, and X-ray analyses (4, 5) 
have been carried out on peptides related to the acceptor sequence. 
In all cases a clear indication emerges that the presence or absence 
of acceptor properties could be related to secondary structure 
forming tendencies in solution. Specifically, l3-turn (2), "loop" (3b) 
and Asx-turn (5) conformations have been proposed. 
X-ray crystal structures have been used to analyze the 
conformations which occur in the polypeptide backbone of several N-
glycoproteins (6). These studies suggest that there may be a 
preference for carbohydrate attachment at external bends of protein 
structure. For example, in virus haemagglutinin, hemocyanin, and (l-
lactalbumin, the carbohydrates were shown to be attached at -Asn-
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Xaa -Thr/Ser- sites located within 13 -turns. Aubert et al. (2) and 
Beeley (7) analyzed a number of known glycoproteins with the 
predictive procedures of Chou and Fasman (8), and concluded that 
there was a high statistical probability for glycosylated asparagine 
residues to be located within l3-turn s . 
The 13 -turn is a fundamental structural motif found in proteins 
which induces the polypeptide chain to reverse its overall direction. 
l3-turns were first described by Geddes (9) and later characterized 
by Venkatachalam (10). They involve four amino acid residues 
(numbered ito i+3) (Figure 4-1) and are classified according to the 
backbone dihedral angles of the central residues in the turn (11) . 
i 
Figure 4-1 Representation of a type I l3-turn. 
l3-turns are stabilized by a hydrogen bond between the amide proton 
of residue i+3 and the carbonyl oxygen of residue i. Turns are 
frequently located at the surface of proteins and are usually 
composed of polar amino acid residues. These polar side chains are 
generally directed outward due to steric congestion. Biological 
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activity has often been related to (3-turn formation in proteins; for 
example, turns serve frequently as sites for receptor binding, 
antibody recognition and post-translational modification. The 
intrinsic compactness and the exposure of side chains in (3 - turns 
makes them ideal recognition elements. However it is unclear 
whether these biological roles are due strictly to conformational 
recognition or due instead to propitious surface localization. In 
regard to glycosylation, it is important to remember that this process 
is a co-translational event and thus the structure observed in the 
final globular protein does not necessarily reflect the polypeptide 
conformation that was present at the time of modification. The 
amount of secondary structure present in nascent polypeptide chains 
during glycosylation is not known. 
The amount of folding present in exogenous small acceptor 
peptides is also relevant to the discussion of transferase recognition. 
Ac -Asn-Ala-Thr-NH2 is the smallest peptide to be glycosylated in 
vitro (12). Accordingly this tripeptide sequence must possess at 
least the main conformational requirements for the enzymatic 
process. Small peptides exist in aqueous solution as statistical 
mixtures of flexible conformers. However, it has been observed that 
significant populations of (3-turn conformations exist in short linear 
pep tides in aqueous solution (13). It has also been demonstrated 
that small pep tides assume ordered conformations when they are 
transferred into hydrophobic environments or into solvents less 
polar than water (14). Since glycosylation most likely occurs at or 
close to the membrane interface, the peptidyl acceptor is likely to 
adopt a defined conformation. Thus, it is possible that a turn 
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conformation could occur and therefore the structure forming 
potential of the acceptor should be considered. 
Statistical analyses of J3-turns in proteins of known structure 
have clearly shown that there are residues which occur more 
frequently in turns, and also that there are strong positional 
preferences for some residues (15). Polypeptides composed solely of 
L-amino acids tend to adopt type I J3-turn conformations. 
Interestingly, Asn residues favor the j + 1 position of these turns. 
There are two type I J3-turns that Ac-Asn-Ala-Thr-NH2 could 
adopt (Figure 4-2). In Figure 4-2, structure a, the carbonyl oxygen 
of the acetyl bocking group is hydrogen bonded to the backbone 
amide of the hydroxy amino acid. In structure b, the carbonyl 
oxygen of the asparagine is hydrogen bonded to the amide proton of 
the carboxy terminal blocking group. 
a 













In order to produce the proposed hydrogen bond interaction 
between the side chains of asparagine and the hydroxy amino acid 
within the confines of a J3-turn, the asparagine residue must occupy 
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the i or i +2 position within the j3-turn. This interaction is not possible 
when asparagine is located in the i+i position. Thus although 
structure a is predicted to be the most stable 13 -turn due to positional 
preferences, structure b is the only conformation which brings the 
side chains of Asn and the hydroxy amino acid residue within 
hydrogen bonding distance. This analysis suggests that j3-turn 
formation is unlikely to be important for recognition. The idea that 
j3-turn formation is crucial to glycosylation is further weakened by 
the realization that although Ac-Asn-Pro-Thr-NH2 is not a substrate 
for the transferase (16), it exists as a highly stabilized turn in which 
Asn occupies the i position (17) 
Moreover, Mononen and Karjalainen (IS) observed that, when 
they predicted the secondary structure of a large number of known 
glycoproteins, 70% of the -Asn-Xaa-thr/Ser- sites occurred in 13-
turns, 20% in j3-sheets and 10% in a-helices. Also no difference 
between glycosylated and non-glycosylated sequences was observed. 
Their findings were later confirmed by Gavel and von Heijne (19) 
who calculated the j3-turn, j3-sheet, and a-helix potentials as a 
function of position using an improved scale. They found no 
indications that glycosylated -Asn-Xaa-Thr/Ser- sites were more 
prone to form j3-turns than non-glycosylated -Asn-Xaa-Thr/Ser-
sites. Thus the involvement of j3-turn conformation in glycosylation 
is not substantiated. 
Another conformation which has been suggested to facilitate a 
hydrogen bond interaction between Asn and Thr is a (i+4) "loop 
structure" (3 b). This conformation was loosely described by Bause 
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as a turn composed of five instead of four amino acid residues 
(Figure 4-3). 
HN---<... 
o o OH 
Figure 4-3 Representation of the (i +4 ) loop. 
No structural data supports this model. 
The final conformation which has been implicated in 
glycosylation is the Asx-turn (4). The Asx-turn is topologically 
equivalent to the ~-turn. It is characterized by an interaction closing 
a lO-membered cycle and involving the side chain carbonyl oxygen 
of an Asn or Asp residue and the amide proton of the peptide group 
two residues ahead in the sequence (Figure 4-4) (20). 
Figure 4-4 Representation of an Asx-turn. 
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Although the Asx-tum occurs less frequently than the j3-tum, about 
18% of Asn and Asp residues in proteins occur in this conformation. 
Asx-tums have been identified in the crystal structures of a-
chymotrypsin, prealbumin, and carboxypeptidase A (21). 
An analysis of the acceptor Ac-Asn-Ala-Thr-NH2 indicates that 




Figure 4-5 The possible Asx-tum structure of Ac-Asn-Ala-Thr-NH2. 
structure would facilitate an interaction between the side chains of 
Asn and Thr. 
More structural information is needed to either consolidate one 
of the proposed conformational models, or to determine if indeed 
solution conformational tendencies play any role in the glycosylation 
process. Thus, a series of tripeptides which contained the -Asn-Xaa-
Thr/Ser- marker sequence and differed in the nature of the central 
residue were investigated. This study included an evaluation of the 
properties of each peptide as oligosaccharide acceptors in the 
transferase assay and a parallel examination of the solution 
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conformational properties using a combination of 1- and 2-D NMR 
experiments. 
EXPERIMENTAL MErnODS 
The solution conformations of six peptides (Ac-Asn-Ala-Thr-
NH2, Ac-Asn-Leu-Thr-NH2, Ac-Asn-Asp-Thr-NH2, Ac-Asn-(D)Ala-
Thr-NH2, Ac-Asn-Pro-Thr-NH2, Ac-Asn-AIB-Thr-NH2) were 
examined through the use of amide proton temperature coefficients, 
3JHNa coupling constants (22) and NOE studies. The information on 
through-space interactions was observed through the use of a 
CAMELSPIN or 2-D ROESY NMR experiments (23) in dimethyl 
sulfoxide. This polar, but aprotic, solvent was chosen since it can be 
considered to mimic the polar membrane interface where the 
nascent polypeptide substrate and the membrane associated enzyme 
oligosaccharyltransferase are localized better than either water or a 
non-polar organic solvent. Also, it has been shown that 
oligosaccharyltransferase-catalyzed glycosylation is significantly 
enhanced in the presence of non-denaturing levels (up to 13.5%) of 
dimethyl sulfoxide (24). This effect might be due to an increase in 
the population (as observed by CD studies) of a peptide conformer 
recognized by the oligosaccharyltransferase. 
4.1 Peptide Synthesis 
The following peptides were synthesized using known solution 
phase methods (26): Ac-Asn-Pro-Thr-NH2, Bz-Asn-Pro-Thr-NHMe, Ac-
Asn-Leu-Thr-NH2, Bz-Asn-Leu-Thr-NHMe, Ac-Asn-Ala-Thr-NH2, Ac-
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Asn-(D)Ala-Thr-NHZ, Bz-Asn-(D)Ala-Thr-NHMe. A series of generalized 
reaction procedures is outlined below. 
BOC-Xaa-Thr-OMe 
To a solution of cold threonine methyl ester (0.85g, 5 mmol) in 5 
mL of DMF was added triethylamine (693 ~L, 5 mmol). A solution of 
dicyc1ohexylcarbodiimide (5.3 mmol), I-hydroxybenzoltriazole (5.3 
mmol), and BOC-Xaa-OH (5.3 mmol) was added slowly with stirring. The 
reaction was stirred for 12 h. Dicyc10hexylurea was filtered off and 
rinsed with DMF. The reaction mixture was concentrated in vacuo. The 
oily residue was flash chromatographed (Rf 0.2 in 10% methanol-
chloroform) to yield the pure dipeptide in about 70% yield. 
BOC-Asn-Xaa-Thr-OMe 
Trifluoroacetic acid (2.85 mol) was added to a solution of BOC-Xaa-
Thr-OMe (1.6 mmol) in 2.85 mL of dichloromethane. The mixture was 
stirred for 2 h and reduced under a stream of argon. The residue was 
taken up in DMF and triethylamine (1.7 mmol) was added. The mixture 
was cooled to O°C. BOC-Asn-OpNp (1.8 mmol) in 2 mL of DMF was added 
dropwise. The reaction was stirred for 12 h. The mixture was then 
concentrated in vacuo. The oily yellow residue was flash 
chromatographed (Rf 0.2 in 10% methanol-chloroform) to yield the 
tripeptide (about 80%). 
BOC-Asn-Xaa-Thr-NHz 
BOC-Asn-Xaa-Thr-OMe (1 mmol) was dissolved in 2 mL of methanol 
saturated with ammonia. The vessel was sealed tightly and stirred for 
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18 h. The mixture was reduced under a stream of argon and 
quantitiatively yielded the title compound. 
Ac- Asn-Xaa-Thr- NH2 
Trifluoroacetic acid (l mL) was added to a solution of BOC-Asn-Xaa-
Thr-NH2 (0.54 mmol) in 1 mL of dichloromethane. The mixture was 
stirred for 2 h and then reduced under a stream of argon. The residue 
was resuspended in 2 mL of 50% aqueous dioxane, cooled to O°C, and 
triethylamine (80 ~I, 0.54 mmol) was added. Acetic anhydride (102 ~L, 
0.54 mL) was added dropwise and the mixture was stirred for 18 h. 
Dioxane was condensed off in vacuo and the remaining aqueous solution 
was purified via Dowex-50 (H+ form) and Dowex-l (OH- form) columns. 
The pure tripeptide was obtained in about 70%. 
BOC-Asn-Xaa-Thr-NHMe 
BOC-Asn-Xaa-Thr-OMe (1 mmol) was dissolved in 2 mL of methanol 
saturated with mono methylamine. The vessel was sealed tightly and 
stirred for 18 h. The mixture was reduced under a stream of argon and 
quantitatively yielded the title compound. 
Bz-Asn-Xaa-Thr-NHMe 
Trifluoroacetic acid (1 mL) was added to a solution of BOC-Asn-Xaa-
Thr-NHMe (0.5 mmol) in 1 mL of methylene chloride. The mixture was 
stirred for 4 h and then reduced under argon. The residue was 
resuspended in 2 mL of dimethylformamide, cooled to O°C, and 
triethylamine (80 ~L, 0.54 mmol) was added. Benzoic anhydride (0.116 
g, 0.54 mmol) in 1 mL dimethylformamide was added dropwise with 
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stirring. The mixture was stirred for 10 h. Dimethylformamide was 
condensed off in vacuo and the residue was purified by preparative TLC 
(Rf 0.5 in 10/1; chloroform/methanol) to yield pure protected tripeptide 
(-80%). 
Ac-Asn-AIB-Thr-NH2 and Bz-Asn-AIB-Thr-NHMe were synthesized 
from BOC-Asn-AIB-Thr-OMe as above, however this material was 
synthesized via the following modified procedure: 
BOC-Asn-AIB-OMe 
To a solution of cold <x-aminoisobutyric methyl ester (0.56 g, 3.6 
mmol) in 5 mL of DMF was added 1 equivalent of triethylamine (504 
ilL, 3.6 mmol). BOC-Asn-OpNp (1.28 g, 3.6 mmol) in 5 mL DMF was 
added dropwise to the reaction mixture. The reaction was stirred for 6 h 
and then concentrated in vacuo. The oily residue was flash 
chromatographed (Rf 0.3 in 5/1 CHCI3/MeOH) to yield 0.90 g (81 %) of 
pure dipeptide . 
BOC-Asn-Aib-OH 
BOC-Asn-Aib-OMe (0.90 g, 2.7 mmol) was saponified in 2.25 mL of 
2 NNaOH. After two hours the reaction mixture was neutralized with 1 
N HCI and lyophilized. The residue was suspended in MeOH and filtered 
to remove salts. 
BOC-Asn-Aib-Thr-OMe 
To a solution of cold threonine methyl ester (0.15 g, 0.88 mmol) in 3 
mL of DMF was added 1 equivalent of triethylamine (123 ilL, 0.88 
mmol). A solution of BOCAsn-Aib-OH (0.3 g, 0.92 mmol), DCC (920 ilL of a 
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1 M solution in DMF). and HOBT (0.124 g. 0.92 mmol) in 1 mL DMF was 
added dropwise to the reaction mixture with stirring. The reaction was 
left for 12 hours and condensed in vacuo. The residue was flash 
chromatographed (Rf 0.45 in 10/1 CHCI3/MeOH) to yield pure tripeptide 
in 71% yield. 
Ac-Asn-Asp-Thr-NH2 and Bz-Asn-Asp-Thr-NH2 were synthesized 
from Boc-Asn-Asp(OBn)-Thr-OMe using the following modified 
procedure. 
Ac-Asn-Asp(OBn) -Thr-OMe 
Boc-Asn-Asp(OBn)-Thr-OMe (0.5 g. 0.84 mmol) was suspended in 2 
mL methylene chloride and 2 mL of trifluoroacetic acid. The solution 
was sealed tightly and stirred 4 h. The mixture was reduced under a 
stream of argon and lyophilized from water. The residue was suspended 
in 3 mL of dimethylformanide and acetic anhydride (95 ilL. 1.01 mmol) 
and triethylamine (140 ilL. 1.01 mmol) were added. The solution was 
stirred for 4 h. The solution was reduced in vacuo. Purification of the 
oily residue via preparative TLC (5/1 chloroform/methanol. Rf 0.4) 
yielded the pure dipeptide (-75%). 
Ac-Asn-Asp - Thr-OM e 
Ac-Asn-Asp(OBn)-Thr-OMe (0.3 g. 0.6 mmol) was suspended in 5 
mL of methanol. Approximately 60 mgs of 5% Pd-C catalyst was added. 
The mixture was hydrogenated at atmospheric pressure for 2 h after 
which time the catalyst was filtered off through a pad of celite. The 
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filtrate was reduced and afforded the product in essentially quantitative 
yield. 
Ac-Asn-Asp-Thr- NH2 
Ac-Asn-Asp-Thr-OMe (0.24 g) was suspended in 3 mL of methanol 
saturated with ammonia. The reaction flask was sealed tightly and 
stirred for 12 h. The solution was reduced under a stream of argon and 
lyopholized from water to yield pure product (-85 % ). 
PHYSICAL DATA 
Ac - Asn -AlB -Th r- NH2 
IH NMR (d6-DMSO) 0: 8.43 (s, lH), 8.18 (d, IH, J = 7 Hz), 7.52 (s, lH), 7.40 
(d, IH, J = 8.6 Hz), 7.11 (s, IH), 7.05 (s, lH), 7.00 (s, lH), 4.61 (d, 
lH, J = 7.9 Hz), 4.46 (q, lH, J = 7 Hz), 4.07 (m, lH), 3.93 (m, lH), 
2.50 (m, 2H), 1.82 (s, 3H), 1.33 (s, 6H), 1.01 (d, 3H, J = 6.4 Hz) 
13C NMR (d6-acetone, D20) d: 177.4, 175.0, 174.5, 174.3, 172.5, 67.1, 
59.2, 57.5, 51.0, 38.6, 24.3, 23.0, 22.0, 19.1 
Mass spectroscopy [MH]+ 360 
TLC (4/1/1; n- butanol/water/acetic acid) Rf = 0.33 
Ac-Asn-(D)Ala-Thr- NH2 
IH NMR (d6-DMSO) 0: 8.33 (d, lH, J = 6.9 Hz), 8.13 (d, lH, J = 7.6 Hz) 7.60 
(d, 1 H, J = 8.7 Hz), 7.39 (s, lH, 7.18 (s, IH) 7.09 (s, lH), 6.94 (s, 
lH), 4.93 (bs, IH), 4.42 (q, lH, J = 6.6 Hz), 4.27 (t, lH, J = 7.3 Hz), 
4.03 (m, 2H), 2.42 (m, 2H), 1.84 (s, 3H), 1.22 (d, 3H, J = 7.1 Hz), 
0.97 (d, 3H, J = 6.3 Hz) 
13C NMR (d6-acetone, D20) 0: 175.5, 174.8, 174.6, 174.5, 172.9, 67 .1, 
58.9, 50.9, 50.2, 37.0, 22.1 , 19.0, 18.8 
Mass spectroscopy [MH]+ 346 
TLC (4/1/1; n-butanol/water/acetic acid) Rf = 0.23 
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Ac-Asn-Ala-Thr- NH2 
lH NMR(d6-DMSO) S: 8.22 (d, lH, J = 7.0 Hz), 8.13 (d, lH, J = 7.1 Hz), 7.60 
(d, lH, J = 8.3 Hz), 7.43 (s, IH), 7.06 (s, lH), 7.03 (s, lH), 6.97 (s, 
lH), 4.79 (d, lH, J = 5.9 Hz), 4.52 (q, lH, J = 6.7 Hz), 4.22 (t, IH, J = 
7.0 Hz), 4.00 (m, 2H), 2.49 (m, 2H), 1.82(s, 3H), 1.22 (d, 3H, J = 
7.1 Hz), 1.01 (d, 3H, J = 6.1 Hz) 
13C NMR (D20, d6-acetone) S: 175.5, 174.6, 174.3, 173.7, 172.9, 67.2, 59.0, 
50.5, 43.5,36.7, 22.1, 19.0, 16.6 
Mass spectroscopy [MH]+ 346 
TLC (4/1/1; n- butanol/water/acetic acid) Rf = 0.23 
Ac-Asn-Leu-Thr-N H2 
IH NMR (d6-DMSO) S: 8.15 (m, 2H), 7.60 (d, lH, J = 8.4 Hz), 7.44 (s, IH), 
7.04 (s,2H), 6.95 (s, lH), 4.90 (bs, lH), 4.50 (t, lH, J = 7.0 Hz), 4.23 
(q, lH, J = 7.4 Hz), 4.02(m, 2H), 2.46 (m, 2H), 1.82 (s, 3H), 1.59 
(m, IH), 1.51 (m, 2H), 1.00 (d, 3H, J = 6.2 Hz),0.86 (d, 3H, J = 6.5 
Hz), 0.81 (d, 3H, J = 6.4 Hz) 
13C NMR (D20, d6-DMSO) S:175.0, 174.6, 174.3, 174.2, 173.167.2, 59.0, 
53.0, 51. 1 ,50.8, 39.9, 36.5, 29.8, 29.5, 29.3, 24.6 
Mass Spectroscopy [MH]+ 388 
TLC (4/1/1; n-butanol/water/acetic acid) Rf=0.47 
Ac-Asn- Pro-Thr-N H2 
IH NMR (d6-DMSO) S: 8.27 (d, IH, J = 7.8), 7.62 (m, 2H), 7.09 (s, lH), 6.86 
(s, lH), 4.80 (q,lH, J = 7.1 Hz), 4.31 (q, lH, J = 5.2 Hz), 4.02 (m, 
2H), 3.68 (m, 2H), 2.45 (m, 2H), 2.06(m, lH), 1.87 (m, 3H), 1.80 
(s, 3H), 1.03 (d, 3H, J = 6.3 Hz) 
13C NMR (D20, d6-acetone) S: 174.7, 174.2,173.9, 171.7, 67.1, 61.3, 59.0, 
48.3, 48.2,36.4, 29.9, 24.9, 21.9, 19.2 
Mass Spectroscopy [MH]+372 
TLC (4/1/1; n-butanollwater/acetic acid) Rf= 0.40 
Ac- Asn - Asp- Th r- NH 2 
IH NMR (d6-DMSO) S: 8.34 (d, lH, J = 6.4 Hz), 8.19 (d, lH, J = 7.3 Hz), 7.53 
(d, lH, J=8.4 Hz), 7.42 (s, lH), 7.11 (s, lH), 7.07 (s, lH), 6.97 (s, 
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IH), 4.78 (bs, lH), 4.49 (m,2H), 4.01 (m, 2H), 2.50 (m, 4H), 1.85 
(s, 3H), 0.97 (d, 3H, J = 6.3 Hz) 
13C NMR (d6-DMSO) 0: 172.1,171.7,171.4, 170.7, 169.7, 66.3, 58.7, 50.2, 
49.9, 37.2, 22.5, 20.1 
Mass Spectroscopy [MH]+390 
TLC (4/1/1; n- butanol/water/acetic acid) Rf=O.l1 
Bz-Asn- Pro-Thr-NHMe 
IH NMR (d6-DMSO) 0: 8.60 (d, lH, J = 7.2 Hz), 7.74 (d, 2H, J = 7.4 Hz), 7.42 
(m, 3H ), 7.33 (t, 2H, J = 7.5 Hz), 7.23 (d, IH, J = 4.2 Hz), 6.94 (s, 
lH ), 4.89 (q, lH, J = 7.1 Hz),4.52 (d, lH, J = 5.4 Hz), 4.23 (m, lH), 
3.94 (m , 2H), 3.69 (m , 2H), 2.49 (m, 2H), 2.45 (d , 3H, J = 4.5 
Hz), 1.95 (m , lH), 1.78 (m, 3H), 0.89 (d, 3H, J = 6.0 Hz) 
l3C NMR (d6-DMSO) 0: 172.1, 171.5, 170.9, 170.3, 166.1, 133.6, 13 1.5, 
128.3, 127.6, 66.2, 60.4, 58.6, 48.6, 47.1, 36.8, 29.1, 25.8, 24.5, 
20.2 
Mass Spectroscopy [MH]+448 
TLC (5/1; chloroform/methanol) Rf = 0.54 
Bz-Asn-AIB-Thr-NHMe 
IH NMR (d6-DMSO) 0: 8.51 (d, lH, J = 6.7 Hz), 8.42 (s, lH), 7.72 (d, 2H, J = 
7.5 Hz), 7.39 ( m, 5 H), 7.18 (d, IH, J = 8.7 Hz), 6.94 (s, 1 H), 
4.58 (q, lH, J = 6.9 Hz), 4.54 (bs,lH), 3.96 (bs, lH), 3.87 (m, 2H), 
2.44 (d, 3H, J = 4.3 Hz), 1.21 (d, 3H, J = 8.5 Hz), 0.85 (d, 3H, J = 
6.4 Hz) 
13C NMR (d6-DMSO) 0: 173.9, 171.9, 171.8, 170.5, 166.7, 133.8, 13 1.6, 
128.3, 127.5, 
69.2, 66.2, 58.8, 50.4, 51.1, 36.8, 25.8, 25.6, 24.6, 20.2 
Mass Spectroscopy [MH] +436 
TLC (5/1; chloroform/methanol) Rf = 0.48 
Bz -Asn - As p- Thr-NH2 
IH NMR(d6-DMSO) 0: 8.47 (d,lH, J = 7.3 Hz), 8.28 (d, 1 H, J = 7.5 Hz), 7.71 
(d, 2H, J = 7.4 Hz), 7.35 (m, 5H), 6.96 (d, 2H, J = 9.2 Hz), 6.84 (s, 
IH), 4.63 (m, 2H), 4.45 (q, lH, J = 6.9 Hz), 3.90 (m, 2H), 2.49 (m, 
4H), 0.86 (d, 3H, J = 6.0 Hz) 
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13C NMR (d6-DMSO) 0: 172.1, 172.0, 171.8, 171.4, 170.5, 166.5, 133.9, 
131.5, 128.3, 127.5, 66.3, 58.4, 50.8, 49.9, 36.9, 35.7, 20.0 
Mass Spectroscopy [MH]+ 452 
TLC (4/1/1; n-butanollwater/acetic acid) Rf=0.42 
Bz Asn-(d)-Ala-Thr-NHMe 
IH NMR(d6-DMSO) 0: 8.59 (d, 1 H, J = 6.9 Hz), 8.02,(d, lH, J = 6.7 Hz), 7.72 
(d, 2H , J = 7.2 Hz), 7.61 (d, IH, J = 7.8 Hz), 7.49 (s, 1 H), 7.40 (q, 
lH, J = 7.2 Hz), 7.34 (d, 2H ,J = 7.6 Hz), 7.27 (s, lH), 6.82 (s, lH), 
4.68 (d, lH, 5.5Hz), 4.59 (q, lH, J = 6.1 Hz), 4.22 (d, lH, J = 7.0 Hz), 
3.93 (m, 2H), 2.49 (m, 5H), 1.10 (d, 3H, J = 6.9 Hz), 0.84 (d, 3H, J 
= 5.9 Hz) 
13C NMR (d6-DMSO) 0: 172.4, 171.6, 171.0, 166.8, 133.8, 131.6, 128.3, 
127.5, 66.3, 58.5, 51.0, 48.6, 36.9, 25.7, 20.0, 18.0 
Mass Spectroscopy [MH]+ 422 
TLC (5/1; chloroform/methanol) Rf=0.38 
Bz-Asn-Leu-Thr-N HMe 
IH NMR (d6-DMSO) 0: 8.64 (d, lH, J = 7.5 Hz), 8.20 (d, lH, J = 8.0 Hz), 7.83 
(d, 2H, J = 7.4 Hz), 7.60 (d, lH, J = 8.7 Hz), 7.50 (m, 4H), 6.98 (s, 
lH), 4.83 (d, lH, J = 5.4 Hz), 4.74 (q, lH, J = 6.2 Hz), 4.29 (m, lH), 
4.04 (m, IH), 4.00 (m, lH), 2.57 (m, 5H), 1.59 (m,lH), 1.52 (m, 
2H), 0.98 (d, 3H, J = 6.3 Hz), 0.84 (d, 3H, J = 6.5 Hz), 0.79 (d, 3H, J 
= 6.5 Hz) 
13C NMR (d6-DMSO) 0: 176.7, 171.9, 171.7, 171.3, 171.2, 131.3, 128.1, 
127.3, 107.6, 66.2, 58.3, 51.6, 36.5, 24.0, 23.0, 21.3, 19.9 
Mass Spectroscopy [MH]+ 464 
TLC (5/1; chloroform/methanol) Rf = 0.42 
4.2 NMR Spectroscopy 
Ac-Asn-Leu-Thr-NH2, Ac-Asn-Ala-Thr-NH2, Ac-Asn-Asp-Thr-
NH2, Ac-Asn-Pro-Thr-NH2, Ac-Asn-AIB-Thr-NH2 and Ac-Asn-
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(D)Ala-Thr-NH2 were pretreated by co-evaporation with 
deuteriochloroform and subsequently dissolved in d6-dimethyl 
sulfoxide (concentration approximately 4 mg/mL, 10 mM). 
NMR experiments were performed at ambient temperature 
(298 K) unless otherwise noted . Peak assignments were determined 
either in I-D by homonuc1ear single frequency decoupling 
experiments or through the use of a 2-D I H COSY experiment. In the 
former case the decoupler power used was maintained at the 
minimum required to instantaneously saturate the peak of interest. 
2-D ROESY spectra were obtained in phase sensitive mode and were 
multiplied by a squared sine bell apodization function prior to 
Fourier transformation. The spectral widths in both dimensions were 
typically 5000 Hz. NOE's were detected using the 2-D spin-locked 
ROESY experiment, which is best suited to the detection of NOE 
effects in relatively small systems (MW 400-1500). These spectra 
were recorded at 299 K. In this experiment the spin lock was 
achieved by applying a 200 millisecond pulse through the decoupler 
channel. The relaxation delay was 1.5 s. The transmitter offset was 
positioned in the center of the spectrum. The ROESY experiment 
conditions (namely mixing time, radiofrequency power and offset 
frequency) were varied in initial studies in order to verify that NOE 
connectivities observed represented proximity and did not in fact 
result from Hartman-Hahn magnetization transfer (26). The data 
matrix consisted of 256 t1 increments containing IK complex points. 
It should be noted that the ROESY cross peaks, while useful in 
obtaining qualitative proximity information «3A) could not be easily 
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used to derive quantitative distance information in the same way as 
NOESY data (27). 
The temperature dependence of the assigned amide proton 
shifts was determined between 299 K and 325 K. In all cases the 
chemical shift was found to vary linearly with temperature. A 
minimum of six temperature steps were recorded in each 
experiment. Temperature calibration of the actual probe 
temperature was performed using an ethylene glycol standard . 
4.3 Olil:osaccharyltransferase Assay 
The oligosaccharyltransferase assay was performed as 
described in chapter 2.3.1. 
RESULTS AND DISCUSSION 
The eleven tripeptides examined in the oligosaccharyl 
transferase assay belong to two homologous series differing only in 
the protecting groups used at the carboxyl and amino termini. Six of 
the tripeptides were blocked at the amino terminus by a benzoyl 
group and a secondary amide at the carboxyl terminus. The benzoyl-
protecting group was used to maximize the detection of any acceptor 
properties related to the polypeptide (as discussed in chapter 2). In 
the second series, the tripeptides were blocked at the amino 
terminus by an acetyl group and by a primary amide at the carboxyl 
terminus. Spectroscopic studies were performed on the acetyl-
protected series since the spectra were devoid of any overlapping 
proton signals in the diagnostic amide region. By examining both 
series of pep tides, the maximum information concerning both 
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acceptor properties and solution conformation were derived. 
Furthermore, substitution of the benzoyl group for the acetyl did not 
appear to perturb the solution conformation in the 2-D experiment. 
The Km values for the peptides are shown in Table 4-1. The 
binding affinities were enhanced, as predicted, when the benzoyl 
group was used as the blocking group. Within the two series, only 
those peptides with L-amino acids in the central position exhibited 
acceptor properties. Interestingly, Bz-Asn-Asp-Thr-NH2 is a 
substrate, albeit far poorer than the corresponding alanine and 
leucine containing peptides. This finding is contrary to original 
reports indicating that peptides containing aspartic acid as the 
central residue were not tolerated in an oligosaccharide acceptor 
(18). The remaining tripeptides were all either very poor or non-
acceptors, regardless of the N-terminal protecting group. 
T bl 41 E a e - nzyme I f assay resu ts rom ·d tnpeptl e d· stu les. 
Km /mMa 
peptide X=Ac, Y=NH2 X=Bz, Y =NHMe 
X-Asn-Leu-Thr-Y 1.0 0.25 
X-Asn-Ala-Thr-Y 2 .0 NDb 
X-Asn-Asp-Thr-Y >50 3.3 c 
X-Asn-Pro-Thr-Y >50 >50 
X-Asn-(D)Ala-Thr-Y >50 >30d 
X-Asn-AIB-Thr-Y >50 >30d 
a Similar Vmax values were obtamed for each pepude; 500 
dpm/min (-5x-3) nmol min- 1 mg-! microsomal protein at a 
DolPPNAGNAG concentration of 8.3 nM 
b Not Determined 
c Y=NH2 
d Residual activity apparent at high peptide concentrations. 
Km lies between 30-50 mM. 
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The amide proton temperature coefficients for the SIX acetyl-
protected peptides are shown in Table 4-2. These values provide a 
measure of the amide proton solvent accessibility and/or hydrogen 
bonding. In polar solvents, coefficients ranging from -4 to -7 ppb/K 
are typical of solvent exposed protons, whereas those in the 0 to -3 
ppb/K range are diagnostic of solvent shielding (values close to 0 
ppb/k have been observed for conformationally constrained cyclic 
peptides in chloroform/dimethyl sulfoxide mixtures (28)). 
Table 4-2 Temperature dependence of amide proton chemical 
shifts (-tJ.0! tJ. T)a for Ac-Asn-Xaa-Thr-NH2b in DMSQc 
Asn Asn Asn Xaa Thr terminus terminus 
I)NH I)NH 
Leu 4.5 4.1 5.4 4.8 2.7 3.7 3.7 
Ala 5.0 4.5 5.7 5.3 3.1 4.0 4.0 
Asp 4.6 3.8 4.8 2.7 1.5 2.9 4.6 
D-Ala 5.0 4.5 3.9 7.6 3.0 5.5 5.4 
AlB 6.1 5.2 6.4 7.2 3.1 5.0 3.3 
Pro 5.5 3.8 2.1 n/a 4.0 6.0 6.0 
a In parts per bIlhon KelvIn. 
b Xaa = Leu, Ala, Asp, D-Ala, AlB, Pro 
c Primary amide proton signals were assigned by comparison 
with analogous peptides from Bz-Asn-Xaa-Thr-NHMe series 
and from 2-D NMR data. 
With the exception of Ac-Asn-Pro-Thr-NH2, the threonine amide 
proton possessed the lowest temperature coefficient. In similar 
studies with threonine-containing peptides which lack the proximal 
asparagine residue, the temperature coefficient for the threonine 
amide proton lies in the "normal" range for an unsequestered proton 
(29). Thus, this effect does not appear to be residue-specific. 
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The 3JHNa coupling constants for the amide protons within the 
tripeptide backbones are shown in Table 4-3. The angular 
dependence of amide proton-Ca coupling constants (3JHNa) has been 
calibrated from protein structure information (22). In general, small 
coupling constants (2-4 Hz) are observed when the <I> dihedral angles 
are in the -30 to _60° range and larger values (7-10 Hz) result from <I> 
values of -100 to _140°. The former angles are associated with 
either regular a-helix secondary structure or the <I> dihedral of the 
n + 1 residue within a type I 13 -turn, while the latter are associated 
with extended 13 -sheet structure, random coil or the <I> dihedral of the 
n+2 residue of a 13-turn (11). 
Table 4-3 Cou plinJl: constants (in Hertz) for Ac-Asn-Xaa-Thr-NH2a. 
Asn Xaa Thr 
Leu 7 . 9 8.4 8.4 
Ala 7.0 7.7 8 .3 
Asp 6.4 7.3 8.4 
D-Ala 6.9 7.6 8 .7 
AlB 7.0 n/a 8.6 
Pro 7.8 n/a 9.1 
a Xaa = Leu, Ala, Asp, D-Ala, AlB, Pro. 
Figures 4-6 to Figure 4-9 shows segments of the ROESY spectra 
for four of the acetyl-protected peptides examined. The 2-D ROESY 
spectrum of a representative peptidyl substrate, Ac-Asn-Ala-Thr-
NH2, is illustrated in Figure 4-6. (The corresponding spectra of Ac-
Asn-Asp-Thr-NH2 and Ac-Asn-Leu-Thr-NH2 are not shown, but 
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Figure 4-6 ROESY spectrum of Ac-Asn-Ala-Thr-NH2 . 
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All substrates are characterized by ROESY cross peaks daN(Ac,Asn), 
daN(Asn,Xaa), daN(Xaa,Thr), NH2.d~N(Thr,terminus), daN(Thr,Thr), 
dpN(Thr,Thr) and daN(Asn,Asn) which are summarized graphically in 
Figure 4-lOa. 
c) Me Me * 
Mey~;~-\~. 0 
AO jH OA,.H 
A • \ HO·/H 
o NH"--' Me-~ 
A 2 
d) 
Figure 4-10 Graphical representations of connectivity and 
hydrogen-bonding information derived from 
spectroscopic studies of six acetyl-protected peptides. 
Key: H NOE connectivity; * hydrogen bond donor; ... 
hydrogen bond acceptor. The structures shown are a) 
Ac-Asn-Ala-Thr-NH2, b) Ac-Asn-D-Ala-Thr-NH2, c) 
Ac-Asn-AIB-Thr-NH2, and d) Ac-Asn-Pro-Thr-NH2. 
The ROESY data for Ac-Asn-(D)Ala-Thr-NH2 is shown in Figure 
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Firstly, the strong backbone sequential connectivity daN(Asn,Xaa) 
observed in the substrates is replaced by a very weak (relative to 
other signals within the same spectrum) crosspeak in Ac-Asn(D)Ala-
Thr-NH2. Instead, a strong intraresidue connectivity daN(Asn, Asn) 
appeared. Also, despite the change in chirality at the (D)alanine aC, 
the sequential NOE daN(dAla,Thr) is still present. This information is 
summarized in Figure 4-lOb. 
The ROESY spectrum for the peptide Ac-Asn-AIB-Thr-NH2 is 
illustrated in Figure 4-8. The first notable feature of the spectrum is 
that the sequential and intraresidue interactions from the asparagine 
aCH are of very similar intensity. However since the AIB-aC is 
disubstituted, no sequential information can be derived for the 
central residue. The key interproton connectivities are illustrated 10 
Figure 4-10c. 
Figure 4-9 illustrates the ROESY spectrum for the non-acceptor 
peptide Ac-Asn-Pro-Thr-NH2. The key crosspeaks observed in the 
ROESY spectrum are doa(Pro,Asn), daN(Pro,Thr) and daN(Thr, 
terminus). These are summarized 10 Figure 4-lOd. 
The three tripeptide substrates appear to share common 
conformational characteristics. First, the threonine NH is shielded 
from the bulk medium as evidenced by the low temperature 
coefficients (-1.5 to -3.1 ppb/K) when compared with other values 
from the same peptide. Thus this amide NH was considered to be 
shielded from the bulk medium by hydrogen-bonding interaction 
within the molecule. Due to ring size and amide constraints only two 
carbonyl groups are likely acceptors in such an interaction. These 


































Figure 4·8 ROESY spectrum of Ac-Asn-AIB-Thr-NH2. 
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Figure 4-9 ROESY spectrum of Ac-Asn-Pro-Thr-Nl1.2 . 
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primary amide carbonyl. If the former interaction were present, the 
daN(Asn,Xaa) connectivity would be absent since this would place 
these protons on the opposite face of the molecule and hence out of 
connectivity range. However, with the latter interaction, the 
daN(Asn,Xaa) would be expected to be strong. The other important 
connectivities observed, notably the strong intra-residue interactions 
in the threonine residue are compatible with a backbone-to-side 
chain H-bonding model. In addition, no other strong NOE 
connectivities are observed, which is in keeping with the above 
model. 
The ROESY spectra of the acceptor peptides also lack 
interproton connectivities diagnostic of typical l3-turn structures that 
generally include dNN(i,i+l) and daN(i,i+2) interactions (30). Instead 
the substrate ROESY spectra reveal five strong sequential 
connectivities between residues along the polypeptide backbone 
indicative of an extended conformation. In addition, the coupling 
constants for the amide protons within the peptide backbone are also 
indicative of an extended backbone conformation. These results are 
consistent with the formation of an Asx-turn. 
An examination of the spectroscopic data for the three 
peptides which are non-binders reveals that these peptides adopt 
conformations in solution which are distinct from those observed for 
substrates. In the (D)alanine containing peptide, while its variable 
temperature data also has a solvent shielded threonine amide, its 
ROESY crosspeak pattern is quite distinct from the pattern observed 
for the substrates. A model consistent with these changes would still 
involve hydrogen-bonding of the threonine NH to the asparagine side 
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chain amide carbonyl oxygen. However, since the methyl group of 
the (D) alanine residue crowds the a-carbonyl group of the adjacent 
asparagine, the amide linking the two residues must rotate by 180
0 
to relieve steric congestion. In this model, the sequential backbone 
interaction, daN(Asn,Xaa), is broken and a strong intraresidue 
connectivity, daN(Asn,Asn), is established. The coupling constants 
observed for this peptide are consistent with this conformation. 
The AlB-containing peptide cannot be compared directly with 
either of the examples described above because of the previously 
mentioned loss of backbone information due to the disubstituted a-
carbon within the peptide backbone. However the variable 
temperature data reveals that two amide protons (ThrNH and 
terminus NH) have low temperature coefficients, and one amide 
(AIB-NH) has a high temperature coefficient analogous to the 
(D)alanine-containing peptide and distinct from the substrate 
peptides. The profound effect that a-amino isobutyric acid has on 
polypeptide conformational behavior has been reviewed by 
Venkataram and Balaram (31). 
Finally, it has long been recognized that peptides containing 
proline as the central amino acid residue seldom act as acceptors in 
transferase assays. Not surprisingly, both the ROESY and variable 
temperature data show that proline allows the peptide to adopt a 
very different solution conformation. The variable temperature 
data for this peptide is quite distinct. One of the asparagine side 
chain amide protons has a low temperature coefficient (-2.1 ppb/K) 
implying that this proton is involved in a H-bonding interaction. 
From examining conformational models, either the proline or 
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threonine carbonyl groups could serve as potential H-bond acceptors. 
In either case, the key interaction between the threonine NH and the 
carbonyl of the asparagine side chain is broken. This may also 
explain why for this case the 3JHNa value of threonine is somewhat 
higher (9.1 Hz). 
CONCl..USIONS 
The three substrates examined share common conformational 
features in solution. These features are consistent with the presence 
of an asparagine side chain to peptide backbone (ThrNH) interaction, 
or an Asx-turn. This interaction could serve to bring the threonine 
and asparagine side chains (crucial elements for glycosylation) into 
close proximity with each other, and hence provide a mechanism 
whereby the functionality of one could influence the reactivity of the 
other. 
Three of the peptides examined (Bz-NPT-NHMe, Bz-N(D)AT-
NHMe, and Bz-NBT-NHMe) show very poor or non-acceptor 
properties. Although it is possible that this diminished binding may 
be due to steric congestion at the enzyme binding site, our study 
suggests that in each case alterations in the backbone conformation 
are deleterious to formation of an Asx-tum as well as to the array of 
potential hydrogen-bonding interactions associated with this 
conformation. 
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With few exceptions short peptides (fewer than 10 residues) 
tend to be unordered in dilute aqueous solutions; that is, they 
adopt a large number of different conformations that are in 
dynamic equilibrium. However, small peptides can adopt defined 
conformations when they bind to receptors. Pinpointing the 
active conformation is relatively difficult because of the large 
number of possible conformations and due to the changing 
demographics of this conformational population as the solvent 
environment changes. Since the major conformations which exist 
in solution may not be relevant to those recognized by the enzyme 
at the active site, the solution conformations of a peptide deduced 
by experimental methods, although interesting in establishing the 
dynamic range of conformations available to a given peptide, are 
not necessarily relevant to the enzyme-bound conformation (1) . 
The design of conformationally constrained peptides is a 
powerful method for elucidating the biologically active 
conformation of a peptide which is recognized by an enzyme (2). 
Conformationally constrained peptides can be used to determine 
which (if any) of the many conformations observed in solution are 
responsible for binding. In addition, conformationally constrained 
peptides bind more tightly to their receptors, because their 
binding occurs with a smaller decrease in conformational entropy 
than the binding of an unconstrained analog (3). 
Various types of conformationally restricted peptides can be 
produced by chemically modifying either the polypeptide 
backbone or the side chain functionalities of various residues (4). 
It is also possible to restrict conformational freedom through 
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short-range cyclizations (5). Cyclizations can be achieved by 
covalent bonding of backbone to backbone groups, side chain to 





Figure 5-1 Constrained peptidyl analogs formed via cyclization 
of a) backbone to backbone groups, b) side chain to 
side chain groups, and c) backbone to side chain 
groups. 
In chapter 4 it was demonstrated that substrates for 
glycosylation share common conformational features 10 solution . 
These features were consistent with the presence of an Asx-turn. 
In an effort to determine if the Asx-turn is the bioactive 
conformation of the polypeptide acceptor, three types of 
constrained analogs were designed and synthesized. These 
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analogs were examined for: greater conformational integrity, 
increased specificity, and increased reactivity. 
The first series of constrained peptides examined were 
constructed via amide bond formation between the peptide amino 
and carboxy termini (cyclizations via backbone to backbone 
groups). Cyclic hexapeptides have proven useful in structural 
studies because they have fewer degrees of freedom than their 
linear analogs, yet they retain sufficient flexibility so that their 
conformations are not strictly dominated by steric interactions. 
Studies on cyclic hexapeptides which contain repeating tripeptide 
sequences have been shown to prefer a conformation which 
contains two i + 3 to i intramolecular hydrogen bonds such that the 
structure is essentially two fused f3-turns (6) (Figure 5-2). 
o 
Figure 5·2 Predominant solution conformation of a cyclic 
hexapeptide . 
Incorporation of proline residues into these cyclic peptides further 
reduces their flexibility. The presence of proline also reduces the 
number of possible f3-turn conformers, since proline can occupy 
only the i + 1 or i + 2 positions. Flexibility is further restricted by 
incorporation of a D-aromatic residue following the proline. 
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Kopple extensively studied cyclo(L-Xaa-L-Pro-D-Pheh peptides 
and concluded that these peptides consisted of two type II 13-turns 
with the amide protons of the Xaa residue solvent shielded and 
transannularly hydrogen bonded . Crystal structure analysis of 
these peptides demonstrated that the 4~ 1 hydrogen bonds were 
bent out of the plane of the 13-turn and were thus relatively weak. 
Gierasch et at. (7) improved on the two turn cyclic hexpeptide 
model by retaining only one Pro-D-Phe sequence and thereby 
increasing the flexibility at the turn formed opposite to it. Their 
peptide, cyclo(Pro-D-Tyr(OBzI)-Gly-Ile-Leu-Gln), was determined 
to exist in one preferred conformation which was composed of two 
13-turns with two strong transannular hydrogen bonds (Figure 5-
3). 
Figure 5-3 Predominant solution conformation of cyclo(Pro-D-
Tyr(OBzI)-Gly-Ile-Leu-Gln). 
Incorporation of an Asn-Xaa-Thr sequence into a cyclic 
hexapeptide which also contains a Pro-D-Phe sequence will fix the 
marker sequence within a type II 13-turn. The marker sequence 
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can be positioned within the /3-turn by frameshifting the 
asparagine into either the i or the i+l position (Figure 5-4). 
Figure 5-4 The two possible cyclic hexapeptides which 
incorporate both a Pro-D-Tyr and an Asn-Xaa-Thr 
sequences . 
By examining the substrate behavior of these cyclic hexapeptides, 
the importance of /3-turn formation in glycosylation can be 
conclusively established. Additionally, the positional preference 
. of the asparagine within the marker sequence can be probed. 
The second series of constrained analogs examined consists of 
peptides containing disulfide bonds (cyclization via side chain to 
side chain groups). Bause et al. (8) examined a series of peptides 
which contained two cysteine residues in various positions 
relative to the marker sequence (Table 5-1). 
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Table 5-1 Glycosyl-acceptor properties of linear and cyclic 
peptides. The essential asparagine and threonine 
residues are shown in bold 
Vmax IKm 
peptide linear cyclic 
CYNGTSVCG 9.6 0.7 
CYNGTTCG 1.5 0.1 
CYNCTSV 3.3 3.5 
CNGTSVCG 1.5 0.6 
CNGTSCG 1.2 0.07 
CNGTCG 0.2 0.0 
TNGTSV 1.0 nla 
In general the cyclic peptides show, with the exception of the 
CYNCTSV, a lower ability to function as glycosyl acceptors than 
their linear counterparts. Cyclization of the linear peptides by 
disulfide bond formation was accompanied by drastic increases in 
Km as well as decreases in Vmax . The exception, CYNCTSV, differs 
from the other peptides in that one cysteine residue is occupying 
the central position of the marker sequence. Disulfide formation, 
in this case, constrains only the asparagine residue; the C-terminal 
peptide segment including the essential threonine remains fully 
flexible (Figure 5-5). 
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Figure 5-5 Energy minimized conformation of cyc1o(CYNC)TSV. 
The marker sequence is boxed and the flexibility of 
the C-terminus is represented with an arrow. 
Bause et al. (8) attempted to correlate their results with the 
ability to form I}-turn structure. However, they did not attempt to 
examine the conformational properties of this series with any 
structural studies. Molecular modelling of the linear compounds 
shown in Table 5-1 does not indicate any particular predispostion 
for I}-turn formation. Nor do their cyclic counterparts lead to any 
major disruptions of the distance separating the asparagine and 
threonine side chain functionalities . The modelling studies do 
indicate that disulfide formation is deleterious to Asx-turn 
formation in all cases except CYNCTSV. For CYNCTSV, an Asx-tum 
is still viable; however, other conformations which are 
characterized by intra-ring hydrogen bonds are preferred. 
Examination of the solution conformations of these disulfide 
containing peptides should help to evaluate the importance of 
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Asx-turn formation in glycosylation. Unfortunately, the Asx-turn 
is not strictly constrained in these analogs. 
To complement the disulfide analogs, a highly constrained 
Asx-turn containing analog was designed. This analog was to be 
cyclized via amide bond formation between the side chain 
carboxyl group of aminopimelic acid (A pm) and the backbone 










Figure 5-6 Representations of cyclo(AsnApm)ThrNMe. 
The lO-membered macrocyc1e thus formed is much less flexible 
than the 14-membered disulfide ring in cyc1o(CYNC)TSV. This 
macrocycle is also composed mainly of methylene units thus 
eliminating the intra-ring hydrogen bond interactions which 
destabilized the Asx-turn in cyc1o(CYNC)TSV. Modelling studies of 
this compound predict that it will form a fairly rigid Asx-turn 
with a cis amide bond at the site of ring closure. In the minimized 
structure of cyc1o(AsnApm)ThrNHMe, the side chain carbonyl 
oxygen of asparagine and the backbone amide of the threonine 
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are 2.6 A apart. This conformation is further stabilized by 
hydrogen bonding interactions between the hydroxyl group of 
threonine and the side chain carbonyl oxygen of asparagine. 
The three types of analogs designed were examined both for 
substrate behavior in glycosylation and for Asx-turn formation. 
The presence of the latter structure was evaluated through the 
use of both nuclear Overhauser effects and amide proton 
temperature coefficients. 
EXPERIMENTAL METHODS 
5.1 Synthesis of cyclic hexapeptides 
Three linear pep tides were synthesized on a Milligen 9050 
automated peptide synthesizer on KA-resin: PYNGTL, PYLNGT, 
and TPFNNA. Peptide couplings were accomplished utilizing 
Fmoc-AA-OPfp esters as the active species and HOBT to prevent 
racemization. Side chain deprotection as well as cleavage of the 
peptide from the resin was accomplished with 9/0.5/0.3/0.2 
TFA/thioanisole/ethanedithiol/anisole. Crude product was 
triturated from TFA with 2/1 Et20/Hexane. Pure product was 
obtained by preparative reverse phase HPLC (Ultrasphere ODS, 5 
~m, 10 mm x 25 cm column). 
Cyclic peptides were obtained by dissolving the linear 
peptides in DMF (0.02 M), neutralizing the N-termini with NMM, 
and activating the carboxyl terminus with 1 equivalent each of 
BOP and HOBT. Cyclization usually proceeded in 24 hrs. Cyclized 
product was readily distinquished from linear precursor by TLC in 
1/1/1/1 HOAc/H20/EtOAc/n-BuOH. The reactions were worked 
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up by condensing the DMF, resuspending the residue in methanol, 
and triturating crude product with Et20. Pure product was 
obtained by preparative reverse phase HPLC (Ultrasphere ODS, 5 
~m, 10 mm x 25 cm column). 
PHYSICAL DATA- NMR are included at the end of the chapter. 
cyclo(PY dNGTL) 
IH NMR (d6-DMSO) 0: 0.9 (m, 6H), 1.1 (d, 3H), l.3 (m, IH), 1.6 (m, 
lH), 1.8 (m, lH), 2.0 (m, lH), 2.65 (m, 2H), 2.6 (m, 2H), 3.2 
(m, lH), 3.4 (m, 2H)4.0 (m, lH), 4.25 (m, 3H) 4.6 (m, 2H), 
6.65 (d, 2H), 6.7 (s, lH), 7.05 (d, 2H), 7.3 (s, lH), 7.6 (d, 
lH), 8.2 (d, lH), 8.9 (d, lH) 
13C NMR (d6-DMSO) 0: 172.01, 171.98, 171.04, 170.80, 170.75, 
169.97, 169.08, 155.56, 129.74, 128.84, 114.81, 65.49, 
60.77, 59.85, 55.33, 50.02, 48.30, 46.47, 44.67, 40.98, 
36.24, 34.91, 27.88, 25.26, 24.02, 23.35, 20.85, 20.55 
Mass Spectroscopy [MH]+ 646 
cyclo(PY dLNGT) 
IH NMR (d6-DMSO) 0: 0.9 (m, 6H), 1.1 (d, 3H), 1.45 (m, IH), 1.55 
(m, lH), 1.6 (m, lH), 2.0 (m, lH), 2.65 (m, 2H), 2.7 (m, 2H), 
3.4 (m, lH), 3.7 (m, IH), 3.8 (m, lHO, 3.9 (m, lH), 4.3 (m, 
lH), 4.4 (m, lH), 4.5 (m, lH), 4.6 (m, IH), 4.8 (m, IH), 4.9 (m, 
lH), 6.65 (d, 2H), 6.9 (s, lH), 7.0 (d, lH), 7.2 (t, lH), 7.4 (s, 
lH), 8.0 (d, lH), 8.3 (m, 2H), 8.4 (d, IH) 
13C NMR (d6-DMSO) 0: 171.91, 171.68, 171.00, 170.35, 170.25, 
168.68, 167.36, 129.9, 127.22, 114.7, 67.26, 61.19, 59.31, 
55.39, 53.32, 51.60, 47.28, 41.47, 40.90, 38.74, 35.72, 31.72, 
28.32, 25.02, 24.00, 22.82, 21.51, 19.03 
Mass Spectroscopy [MH]+ 646 
cyclo(PF dN NAT) 
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IH NMR (d6-DMSO/CDCI3) /): 1.04 (d, 3H, J=6.25 Hz), 1.3 (d, 3H, 
J=7.8 Hz), 1.53 (m, lH), 1.86 (m, 2H), 1.94 (m, lH), 2.54 (m, 
lHO, 2.8 (m, 3H), 3.41 (d, lH, J=11.1 Hz), 3.50 (m, lH), 3.63 
(m, lH), 4.07 (m, lH), 4.2 (m, lH), 4.38 (m, 2H), 4.51 (m, 2H), 
4.63 (bs, lH), 4.67 (m, lH), 6.73 (s, lH), 6.79 (s, IH), 7.11 (m, 
2H), 7.17 (m, 3H), 7.36 (s, lH), 7.90 (D, lH, J=8.7 Hz), 8.39 (d, 
lH, J=6.9 Hz), 8.61 (d, lH, J=8.2), 8.64 (d, lH, J=9.5 Hz), 8.72 
(d, lH, J=9.4 Hz) 
13C NMR (d6-DMSO/CDCI3) /): 173.1, 171.5, 171.4, 170.2, 170.1, 
168.8, 168.7, 138.7, 129.0, 128.8, 127.7, 125.8, 66.46, 61.78, 
55.6, 53.8, 52.5, 50.1, 49.7, 47.0, 40.1, 36.4, 36.2, 35.7, 29.0, 
28.6, 28.7, 27.8, 25.3, 19.5, 19.0, 18.7 
Mass Spectroscopy [MH]+ 645 
5.2 Synthesis of disulfide containin2 peptides 
CYNCTSV and CANCTSA were synthesized on the Milligen 
9050 using FMOC-AA-KA resin and BOP/HOBT couplings. Thiols 
were protected with trityl groups. The linear peptides were 
triturated from MeOH with Et20 until pure by HPLC. Disulfide 
formation was promoted by suspending the pep tides in water 
(0.01 M) and adjusting the pH to 8.5 with Nl40H. The solutions 
were stirred overnight with aeration. Disulfide formation was 
monitored using Ellman's test for free thiol (9). Cyclized products 
were isolated by preparative reverse phase HPLC (Ultrasphere 
ODS, 5 11m, 10 mm x 25 cm column) using a linear gradient (0-40% 
acetonitrile/water over 20 minutes). Disulfide containing 
compounds were retained 13 minutes compared to their reduced 
forms which were retained 22 minutes. 
cyclo(CYNC)TSV 
IH NMR (d6-DMSO) /): 0.81 (q, 6H, J=4.9 Hz), 1.06 (d, 3H, J=6.4 Hz), 
2.06 (m, lH), 2.39 (m, lH), 2.73 (m, lH), 2.9 (m, 3H), 3.05 
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(m, lH), 3.10 (m, lH), 3.2 (m, lH), 3.72 (m, 2H), 4.08 (m, 
lH), 4.17 (m, 2H), 4.27 (m, 2H), 4.39 (t, lH, 1=5.4 Hz), 
4.55 (m, lH), 4.6 (m, IH), 4.83 (m, 1H), 5.05 (m, lH), 6.66 
(d, 2H, 1=8.9 Hz), 6.86 (s, lH), 6.98 (d, 2H, 1=8.4 Hz), 7.42 
(s, lH), 7.57 (d, lH, 1=8.1 Hz), 7.83 (d, 2H, 1=8.4 Hz), 7.87 
(d, 2H, 1=8.0 Hz), 7.95 (d, 2H, 1=8.3 Hz), 8.7 (d, 2H, 1=7.9 
Hz), 9.2 (bs, 1 H) 
13e NMR (d6-DMSO) Ii: 171.9, 170.5, 170.2, 169.8, 169.2, 169.0, 
156.0, 129.9, 126.8, 115.1, 66.5, 61.5, 57.9, 57.3, 54.8, 
52.1, 50.7, 49.8, 36.8, 35.4, 29.9, 18.9, 17.9 
Mass Spectroscopy [MH]+ 787 (exact mass) 
cyclo(CANC)TSA 
lH NMR (d6-DMSO) Ii: 1.03 (d, 3H), 1.24 (m, 6H), 2.65 (m, 2H), 2.71 
(m, lH), 3.07 (m, 3H), 3.60 (d, 2H), 3.97 (s, 2H), 4.17 (t, lH), 
4.29 (m, 3H), 4.42 (m, lH), 4.63 (m, lH), 5.1 (d, IH), 6.85 (s, 
lH), 7.39 (s, lH), 7.44 (d, lH), 7.85 (d, lH), 7.96 (d, lH), 8.05 
(d, lH), 8.23 (d, lH), 8.76 (d, lH) 
13e NMR (d6-DMSO) /):173.76, 171.94, 171.59, 170.15, 169.50, 
169.19, 169.13, 66.55, 61.45, 57.81, 54.81, 52.79, 50.96, 
49.69, 49.50, 47.57, 37.81, 37.28, 35.32, 18.91, 17.56, 17.14 
Mass Spectroscopy [MH]+ 667 (exact mass) 
5.3 Synthesis of the Pimelic macrocycle 
AminopimeJic acid is available from Sigma as the D,L 
racemate. The L-enantiomer can be obtained by acylation 




Concentrated H2S04 (0.8 mL) was mixed with 18 ml Et20. BnOH 
(12 ml, 15 mmol) was added dropwise to this solution and the 
Et20 was blown off with a gentle stream of N2. L-Pimelic Acid (2 
g, 1204 mmol) was added to the solution and stirred at 25°C for 6 
hrs. The solution was diluted with 10 mL EtOH and neutralized 
with pyridine. Crude precipitate was collected, redissolved in 
boiling water, and allowed to cool overnight in the refrigerator. 
1.8 g pure product was obtained (Yield 65%). 
TLC (4/1/1 HAcIH20In-BnOH) Rf=0.2 
Boc-Apm-OBn 
Apm-OBn (104 g, 5.58 mmol) was dissolved in 10 mL 50% aq. 
dioxane. Et3N (1.2 mL, 8.37 mmol) was added and stirred, 
followed by the addition of 1.5 g BOC-ON (6.14 mmol). The 
solution was stirred for 3 hrs at RT after which time the dioxane 
was condensed off. The aqueous layer was acidified to pH 7.0 and 
extracted with EtOAc. The organic phase was dried over NaS04, 
filtered, and condensed (Yield 3.5 g). Crude product was flash 
chromatographed (lOll CHCl3/MeOH Rf=0.25) and yielded 1.63 g 
pure product (Yield 81 %). 
IH NMR (CDCI3) 0: 1.35 (s, 9H), 1.37 (m, 2H), 1.66 (m, 3H), 1.87 (m, 
lH), 2040 (t, 2H), 4.38 (m, lH), 5.12 (s, 2H), 7.42 (m, 5H) 
Boc-Apm(OBn)-Thr-OMe 
Et3N (180 mL, 0.86 mmol) was added to 0.179 g HCl.Thr-OMe 
(0.66 mmol) in 2 mL THF and the solution was stirred. HOBT 
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(0.098 g, 0.73 mmol) and 0.194 g DCC (0.73 mmol) were added to 
0.266 g Boc-Apm(OBn) in 3 mL THF. This solution was added 
dropwise to the Thr-OMe solution. Reaction was stirred overnight. 
DCU was filtered off and rinsed with 2 mL THF. THF was 
concentrated and the residue was purified via flash 
chromatography (8/1 Et20/Hexane). Pure product was obtained 
(0.22 g, 62%). 
IH NMR (CDCI3) II: 1.2 (d, 3H), 1.43 (s, 9H), 1.65 (m, 3H), 1.86 (m, 
lH), 2.37 (t, 2H), 3.75 (s, 3H), 4.11 (m, lH), 4.34 (m, lH), 
4.56 (m, lH), 5.05 (d, lH), 5.11 (s, 2H), 6.80 (d, lH), 6.88 
(d, 1H), 7.34 (m, 5H) 
Boc- Asn- Apm (OB n) · Thr·OMe 
Boc-Apm-Thr-OMe (0.383 g, 0.798 mmol) was dissolved in 4 mL 
50% TFA/Me2CI2. The reaction was stirred for 20 minutes after 
which the TFA was blown off with a gentle stream of N2 . Me2Cl2 
was condensed and the residue was dried with 5% toluene/MeOH 
until traces of TFA were gone. Residue was redissolved in 2 mL 
DMF and 221 ilL Et3N (1.59 mmol). Boc-Asn (0.177 g, 0.76 mmol), 
0.103 g HOBT , and 0.338 g BOP were dissolved in 2 mL DMF and 
added dropwise to the TFA salt solution. Reaction was stirred for 
10 hrs after which DMF was condensed off. Residue was flash 
chromatographed (20/1 CHCI3/MeOH Rf = 0.45) and yielded 0.43 
g pure product (yield 92%). 
The synthesis was also performed with D,L-pimelic acid. 
The diastereomers (DS) could be separated at this stage by flash 
chromatography (20/1 CHC13/MeOH; Rf DS-1=0.5, Rf DS-2=0.45). 
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DS-2 was determined to be the L,L,L tripeptide by comparison 
against the L,L,L tripeptide obtained above. 
1 H NMR (d6-DMSO) 0: 1.05 (d, 3H), 1.17 (t, 2H), 1.37 (s, lOH), 1.54 
(m, 3H), 1.68 (m, lH), 2.3 (t, 2H), 2.45 (m, 2H), 3.6 (s, 3H), 
4.1 (m, lH)' 4.24 (m, 2H), 4.38 (m, lH), 5.07 (s, 2H), 6.9 (s, 
lH), 7.0 (d, 2H), 7.30 (s, lH)' 7.32 (m, 5H), 7.74 (d, lH)' 
8.03 (d, IH).lO (s, 2H), 6.13 (s, IH), 7.10 (s, lH)' 7.34 (m, 
5H), 7.48 (d, lH), 7.71 (d, lH) 
l3e NMR (d6-DMSO) 0: 172.6, 171.9, 171.6, 171.1, 170.8, 155.1, 
136.2, 128.4, 127.8, 126.8, 124.2, 118.9, 78.2, 66.2, 66.1, 
57.8, 51.8, 51.6, 51.2, 45.7, 37.0, 36.4, 33.4, 31.2, 28.0, 
24.2, 24.0, 19.9, 8.5 
Boc-Asn- Apm-Thr- OMe 
Boc-Asn-Apm(OBn)-Thr-OMe (0.0795 g,O.135 mmol) was 
dissolved in 2 mL of MeOH and flushed with N2. Palladium (10 
mg, 5% absorbed on carbon) was added and solution was again 
flushed with N2. Solution was hydrogenated at atmospheric 
pressure with vigorous stirring for 35 min. Palladium was filtered 
off through celite and rinsed with 50% aq. MeOH. 52 mgs pure 
product was obtained (Yield 78%). No further product was 
obtained after rigorously rinsing both flask and celite. 
Subsequent reactions ranged in yields from 70-92%. 
IH NMR (d6-DMSO) 0: 1.04 (d, 3H), 1.27 (m, 2H), 1.46 (s, 9H), 1.48 
(m, 3H), 1.65 (m, IH), 2.17 (t, 2H), 2.34 (m, 2H), 3.6 (s, 
3H), 4.10 (m, lH), 4.23 (m, 2H), 4.38 (m, lH), 4.9 (s, IH), 
6.87 (s, IH), 6.99 (d, lH), 7.27 (s, lH), 7.72 (d, lH), 8.04 
(d, IH) 
13e NMR (d6-DMSO) 0:174.3, 172.0, 171.6, 171.1, 170.8, 155.1, 
78.2, 66.2, 57.8, 51.9, 51.7, 51.2, 36.9, 33.5, 31.9, 28.1, 
24.4, 24.2, 19.9 
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Boc -Asn - Apm - (Asn - A pm (0 Bn) -Thr- OM e) -Thr-O M e 
Boc-Asn-Apm(OBn)-Thr-OMe (0.033 g,O.05 mmol) dissolved in 1 
mL 50% TFA/Me2CI2. The reaction was stirred for 20 minutes 
after which the 1FA was blown off with a gentle stream of N2 . 
Me2Cl2 was condensed and the residue was dried with 5% 
toluene/MeOH until traces of TFA were gone. Residue was then 
dissolved in 0.25 mL DMF and 5.6 ilL Et3N (0.055 mmol). Boc-
Asn-Apm(OH)-Thr-OMe (0.025 g, 0.05 mmol) and 0.024 g BOP 
were dissolved in 0.25 mL DMF and added dropwise to the TFA 
salt solution. Reaction was stirred for 10 hrs after which DMF was 
condensed off. Residue was flash chromatographed (20/1 
CHCI3/MeOH Rf 0.23) (yield 52%). 
IH NMR (d6-DMSO) 0: 0.8 (d, 6H), 1.0 (t, 5H), 1.2 (s, llH), 1.4 (m, 
5H), 1.9 (t, 2H), 2.1 (t, 2H), 2.4 (m, 4H), 3.4 (d, 6H), 4.0 (m, 
2H), 4.1 (m, lH), 4.25 (m, 2H), 4.8 (s, 2H), 7.1 (m, 5H). 
Pimelic dimer Boc-Asn-Apm-(Asn-Apm(OBn)-Thr-OMe)-Thr-
OMe (0.040 g, O.055 mmol) was dissolved in 1 mL of MeOH and 
flushed with N2. Palladium (10 mg, 5% absorbed on carbon) was 
added and solution was again flushed with N2 . Solution was 
hydrogenated at atmospheric pressure with vigorous stirring for 
35 min. The palladium was filtered off through celite and rinsed 
with 50% aq. MeOH. The residue was dissolved in 1 mL 50% 
TFA/Me2CI2 and stirred for 20 minutes. TFA was blown off with a 
gentle stream of N2. Me2Cl2 was condensed and the residue was 
dried with 5% toluene/MeOH until traces of TFA were gone. 
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IH NMR (d6-DMSO) II: 1.01 (m, 6H), 1.3 (m, 4H), 1.5 (m , 6H), 1.6 
(m, 2H). 2.1 (t, 2H), 2.2 (t, 2H), 2.4 (m, 4H), 3.6 (d, 6H), 4.0 
(m, lH), 4.1 (m, 2H), 4.2 (m, 2H), 4.3 (m, lH), 4.4 (m, lH), 
4.5 (m, lH), 4.6 (m, IH), 5.0 (s, lH), 6.7 (s, IH), 7.2 (s, lH), 
7.4 (s, lH), 7.6 (s, lH), 7.8 (d, lH), 8.0 (d, lH), 8.1 (d, IH), 
8.2 (d, lH), 8.4 (d, lH) 
13C NMR (d6-DMSO) II: 174.3, 172.1, 171.9, 171.8, 171.6, 170.9, 
170.8, 66.1, 57.9, 52.3, 52.0, 51.7, 49.3, 41.4, 41.0, 40.8, 
40.0, 37.0, 36.1, 35.0, 33.6, 31.7, 31.5, 24.9, 24.7, 24.5, 
21.6, 20.0, 19.9 
Pimelic macrocycIe 
0.011 g H3N( + )-Asn-Apm-(Asn-Apm-Thr-OMe)-Thr-OMe was 
dissolved in 450 ~L DMF (0.03M) and neutralized with 2 ~L Et3N. 
12.4 mg BOP was added and stirred for I hr after which time 1.5 
eq Et3N (3 ilL, 0.021 mmol) were added. 200 ilL DMF was added 
after 24 hrs to resolubilize the reaction mixture. The reaction was 
allowed to stir a further 48 hrs. DMF was condensed off and the 
residue was triturated from methanol with Et20. The crude 
product was purified by preparative reverse phase HPLC 
(Ultrasphere ODS, 5 11m, 10 mm x 25 cm column) and yielded 6 
mgs. 
IH NMR (d6-DMSO) /):1.0 (m, 3H), 1.1 (m, lH), 1.2 (m , 2H), 1.4 (m, 
3H). 2.1 (t, 2H), 2.4 (m, 2H), 3.4 (d, 3H), 4.1 (m, lH), 4.2 
(m, lH), 4.3 (m, lH), 4.6 (m, IH), 5.0 (s, lH), 6.7 (s, IH), 
7.4 (s, IH), 7.6 (d, lH), 7.8 (d, lH), 8.0 (d, lH) 
13C NMR (d6-DMSO) II: 172.1, 171.8, 171.7, 170.7, 170.6,66.1,57.9, 
51.8, 51.5, 49.3, 40.0, 36.1, 34.7, 31.6, 28.9, 28.7, 28.4, 
24.4, 24.2, 19.8 
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5.4 NMR Spectroscopy on Constrained Anal02s 
NMR experiments were performed at ambient temperature 
(298 K) in d6-dimethylsulfoxide with the exception of 
cyclo(PFdNNAT) which were obtained in 50% CDCI3!d6-DMSO. 2-D 
ROESY spectra were obtained as described in chapter 4.2. 
5.5 Oli20saccharyltransferase Assay 
The oligosaccharyltransferase assay was performed as 
described in chapter 2.3.1. The percentage of dimethylsulfoxide 
was raised to 15% in the assays of the pimelic macrocycle in order 
to solubilize this analog. 
RESULTS AND DISCUSSION 
The cyclic hexapeptides, cyclo(PY dNGlL) and cyclo(PY dLNGT), 
were designed to fix the glycosylation marker sequence within the 
i and i + 1 positions of a type I J3-turn. The Pro-(D)-Tyr sequence, 
which strongly favors a type II J3-turn, was used to encourage the 
adoption of a J3-turn by the remaining four residues. The solution 
conformations of these peptides were analyzed by 1 H-NMR. The 
proton resonances were assigned via a 2-D COSY experiment. 
Table 5-2 illustrates the temperature coefficents for each proton 
in the amide region of cyclo(PY dNGTL) and cyclo(PY dLNGT). As 
discussed in chapter 4, coefficients ranging from -4 to -7 ppb/K 
are typical of solvent exposed protons, whereas those in the 0 to 
-3 ppb/K range are diagnostic of solvent shielding. 
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Table 5-2 Temperature dependence of the amide proton 
chemical shifts (-~o/~ T) for cyclo(PY dNGTL) and 
cyclo(PY dLNGT) in DMSO. 
peptide Tyr Asn Gly Thr 
PYNGlL 6 .94 2 . 15 8.29 6.94 




The ROESY spectra of each peptide are shown in Figures 5-7 and 
5-8 respectively. 
The following observations were made with repect to 
cyc1o(PY dNGTL): 1) small temperature dependencies are seen for 
the Asn and Leu NH resonances, 2) the Gly Ha-NH coupling 
constants are extremely different (9.3 vs. 4.6 Hz), 3) a set of NH(i) 
to NH(i+l) NOE connectivities are seen in the ROESY experiment 
(Leu-NH to Thr-NH and Asn-NH to Tyr-NH), one at each end of the 
molecule, and 4) Pro-aH interacts with Tyr-NH. Figure 5-7 
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Figure 5-7 Graphical representation of connectivIty and 
hydrogen bonding information derived from 
spectroscopic studies of cyclo(PY dNGTL). 
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Cyclo(PY dNGTL) thus appeared to adopt both turns as predicted. 
Asparagine was fixed in the i position of the tum. 
Curiously enough, cyclo(PY dLNGT) did not form the same well 
defined turns. The only amide that exhibited a low temperature 
dependency was Leu-NH. The Gly Ha-NH coupling constants were 
equal indicating that these a protons were magnetically 
equivalent and therefore not constrained. Only one NH(i) to 
NH(i+l) NOE connectivity was seen (Leu-NH to Tyr-NH) indicating 
that only the tum containing the Pro-(D)-Tyr pair was fixed. The 
Pro aH to Tyr-NH interaction was also visible. The lack of 
formation of the second l3-turn was further corroborated by the 
existence of a minor conformation in both the 13C and IH NMR 











Figure 5-8 Graphical representation of connectivity and 
hydrogen bonding information derived from 
spectroscopic studies of cyclo(PY dN G TL). 
for 
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There are a number of possibile explanations as to why 
cyclo(PY dNGTL) doesn't form the second tum. CPK modelling of 
this peptide indicates that most of its functionality is on the same 
face of the macrocycle, unlike cyclo(PY dLNGT). Steric congestion 
may cause the backbone to twist into a more accomodating 
conformation. Alternatively, asparagine's high positional 
preference for the i position within a l3-turn may cause the 
backbone to contort into an alternate loop structure. 
In order to study the effect of asparagine within the i + 1 
position of the tum, a third cyclic hexapeptide, cyclo(PFdNN AT) 
was designed and synthesized. This peptide substituted a second 
asparagine residue for the leucine. Asparagine is smaller than 
leucine and thus it would cause less sterlc crowding, and it should 
also encourage a l3-turn in which the asparagine of the marker 
sequence is fixed in the i+l position. 
The IH- NMR analyses of this compound indicated that the 
second l3-turn formed. The temperature coefficients and 
diagnostic ROESY connectivities are shown in Figure 5-9. 
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Figure 5-9 Graphical representation of connectIvIty and 
hydrogen bonding information derived from 
spectroscopic studies of cyclo(PFdNN A T). 
Temperature coefficients for the amide protons are 
shown. 
The glycosyl acceptor properties for these three peptides 
were determined using standard assay conditions. The peptides 
were examined using 50,000 dpm of Dol-P-P-GlcNAc-PH1GlcNAc. 
The results are shown in Table 5-3. The only peptide which 
exhibited any activity in the transferase assay was 
cyclo(PY dNGTL). The relative activity of this peptide was 100 fold 
lower than the known substrate Bz-NL T-NHMe. Cyclo(PY dLNGT) 
and cyclo(PFdNNAT) had no detectable activity at concentrations 
up to 10 mM. 
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Table 5-3 Enzyme assay results for the cyclic hexapeptides. Bz-
NL T NHMe is included as a standard -
peptide Km (mM) V max (dpm min-i) Vmax/Km 
cVclO(PYclNGTL) 5 -1 0 -250 -40 
cvclo(PY dNGTL) - - -
cyclo(PY dNGTL) - - -
Bz-NLT-NHMe 0.55 2702 4914 
The amount of Dol-P-P-GlcNAc-[3H1GlcNAc was increased to 
200,000 dpm to boost the detection limits of the assay. Figure 5-












-0- Bz-NLT-NHMe 0.5 mM 
- -c- cyclo(PYdNGTL) 5 mM 
- 4 cyclo(PYdLNGT) 5 mM 
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Figure 5-10 Glycosyl acceptor abilities of 0.5 mM Bz-NLT-NHMe, 
5 mM cyclo(PY dNGTL), 5 mM cyclo(PY dLNGT), and 5 
mM cyclo(PFdNNAT). 
It is clear that all three cyclic hexapeptides were extremely poor 
acceptors in the glycosylation assay. Since these pep tides were 
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fixed into J3-turns, it is highly unlikely that this conformation IS 
the active recognition element for glycosylation. 
Cyclo(CYNCTSV) has previously been reported to have 
similar acceptor properties to its reduced form, Iinear(CYNCTSV) 
(8). Thus, although disulfide formation decreases the 
conformational space accessible to this peptide, the active 
conformation must still be populated. The solution conformations 
of cycJo(CANCTSA) and cycJo(CYNCTSV) were examined by IH-
NMR to determine if a major conformation was evident. 
Table 5-4 illustrates the temperature coefficents for each 
proton in the amide region of cycJo(CANCTSA) and 
cycJo(CYNCTSV). 
Table 5-4 Temperature dependence of the amide proton 
chemical shifts (-t./)/t.T) for cycJo(CANCTSA) and 
cycJo(CYNCTSV) in DMSO. 
peptide Xaa-NH Asn-NH Cys-NH Thr-NH Ser-NH Xaa-NH 
cycJo(CANCTSA) 2.4 5.2 1.6 4.6 4.6 5.2 
CycJo(CYNCTSV) 2.1 5.1 1.6 4.0 4.3 5.3 
The portion of the ROESY spectrum of cycJo(CYNCTSV) is shown in 
Figure 5-11. The ROESY spectra for cycJo(CANCTSA) and 
cycJo(CYNCTSV) are equivalent. There are two diagnostic 
connectivities which can seen in the spectra: Ala-NH to Asn-NH 
and Ala-NH to Cys-NH. These connectivities suggest that the 
macrocycJe formed by the disulfide bond is extremely rigid and is 
characterized by intra-ring hydrogen bonding interactions. The 
portion of the polypeptide outside of this ring is extremely 






















Figure 5-12 illustrates the NOE connectivities observed and the 
hydrogen bonding interactions suggested by this data. 
Figure 5-12 Graphical representation of connectIvity and 
hydrogen bonding information derived from 
spectroscopic studies of cyclo(CANCTSA). 
The glycosyl acceptor properties for cyclo(CANCTSA) and 
cyclo(CYNCTSV) were determined using standard assay conditions 
(Table 5-5). 
T bl 55 E a e - nzyme I f h r h assay resu ts or t e cyc IC exa eph es. 
peptide Krn (mM) Vrnax (dpm min-I) Vrnax/Krn 
Bz-NLT-NHMe 0.47 4208 8953 
cycIo(CANCTSA) 2.06 6369 3091 
cycIo(CYNCTSV) 0.33 6402 19400 
The enhanced binding of cyclo(CYNCTSV) compared to 
cyclo(CANCTSA) demonstrates the effect of hydrophobicity on 
binding (refer to chapter 2). Since these pep tides have identical 
solution conformations as determined by IH-NMR, the binding 
efficiency must solely be due to hydrophobic effects. 
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It was previously demonstrated that the linear and cyclized 
forms of CYNCTSV have identical transferase activity (8). 
Although the cyclized form has less degrees of conformational 
freedom than the linear form, the marker sequence is not rigidly 
fixed into any particular conformation. Thus the marker sequence 
is neither fixed into the active conformation nor is it prevented 
from adopting it. This is consistent with the enzymatic data which 
suggests that the active conformation is equally attainable to both 
the cyclized and linear forms. 
Since the tripeptide data in chapter 4 suggested that the 
active conformation was an Asx-turn, a peptidyl acceptor that was 
locked into this conformation was designed. The disulfide 
pep tides discussed above served as a template. Cyclo(Asn-Apm)-
Thr-NHMe is also cyclized from the side chain of its central 
residue, Apm; however, the macrocycle is closed by an amide 
bond between the asparagyl amino terminus and the side chain 
carboxylate of Apm. The macrocycle contains only 10 
heteroatoms and thus should be less flexible than the 14 member 
disulfide ring. 
The final ring closure step in the synthesis of cyclo(Asn-
Apm)-Thr-NHMe proved challenging. This was not unexpected 
due to the highly constrained nature of the macrocycle. 
Cyclization of less sterically hindered ring systems have been 
reported to proceed with low yields (11). The sole product 
isolated from several attempted ring closures was the 
symmetrical dimer shown in Figure 5-13. 
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Figure 5-13 Macromodel representations of the dimeric pimelic 
macrocycle. 
The IH-NMR spectra of this compound contains only one 
resonance for each pair of protons. The dimer appears to be 
rigidly constrained as indicated by: 1) the relative insolubility of 
the compound in most solvents, 2) the stability of the I-D 
solution conformation at elevated temperatures (at least to 330 K), 
and the observation of only one population of NOE connectivities 
(at both 273 K and 330 K). The isolated compound was 
determined to be dimeric by mass spectroscopy. 
The ROESY spectrum of this dimeric material is shown in 
Figure 5-14. 
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Figure 5-14 ROESY spectrum of the dimeric pimelic macrocycle 
inDMSO_ 
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The NOE connectivities observed indicated that the macrocyc1e is 
fixed into Asx-turn conformation. A strong backbone sequential 
connectivity daN(Asn, Xaa) is observed. Also present is a strong 
deN(Apm, Asn) connectivity. The temperature coefficients for the 
amide protons are: Asn-NH = 4.6, Apm-NH = 4.9, and Thr-NH = 
2.4. Thr-NH is the only solvent shielded amide proton (Figure 5-
15). 




N~'>:'" H lr -N" 
o 
o 
Figure 5-15 Graphical representation of NOE connectlvltles and 
the hydrogen bound amides derived from 
spectroscopic studies of the dimeric pimelic 
macrocyc1e. 
The glycosyl acceptor properties for the dimeric pimelic 
macrocyc1e were determined using standard assay conditions 
(Table 5-6). The uncyclized dimer was also examined to 
determine the effect of cyc1ization on enzymatic activity. 
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Since the carboxyl termini of both the linear and cyclized dimeric 
material are methyl esters, the data was also compared against 
the closest versions of the standard substrate which were Boc-
NLT-OMe and Ac-NLT-OMe. 
T able 56 E - nzyme assay 1 f resu ts rom d· Imenc studies. 
peptide Km (mM) V max (dpm min-l) Vmax/Km 
Boc-NLT-OMe l.l3 186 165 
Boc-NXCNXT -OMe)T -OMe1 >302 - -
Ac-NLT-OMe 3.2 524 164 
pimelic macrocycle 0.55 263 478 
1 X = Apm(OBn). 
2 Residual activity was apparent at 15 mM. 
The enzymatic data was surprising for the following reason. The 
linear pimelic dimer, Boc-NX(NXT-OMe)T-OMe, was a very poor 
acceptor. This was unexpected since it is has two potential 
glycosylation sites which are not constrained (Figure 5-16). 
NHBoc 
H2NV .. ··( NH2 
n)=o ~ OH o HN 0 °H 0 
o~~ N0~~OM' 
NH 0 - H 0 




Figure 5-16 Representation of the linear pimelic dimer, 
Boc-NX(NXT-OMe)T-OMe. X = Apm(OBn) 
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Once the macrocycle formed, the compound acquired substrate 
behavior. The relative activity of this macrocyc1e compared to 
Ac-NLT-OMe is slightly deceiving due to the presence of two 
putative glycosylation sites. The data is also complicated by the 
insolubility of the macrocyc1e; at concentrations higher than 20 
mM, the macrocyc1e is only partially soluble. The macrocycle is 
poorly soluble in water which makes performing the assay more 
complicated. It is likely that the actual concentration of the 
compound in the assay is lower than recorded. Thus the velocities 
observed for the macrocycle relate to lower concentrations. It is 
likely that if the macrocycle could be better solubilized, the Vrnax 
would increase. 
Nonetheless, an examination of the kinetic data reveals that 
the macrocycle is 4 fold more active relative to Ac-NLT-OMe. If 
both marker sequences are serving as active acceptors, then the 
activity is still twice as high as the unconstrained standard. More 
importantly, the pimelic containing peptide only acquires activity 
when it is cyclized. Since the solution conformation of this 
compound indicated that it is rigidly fixed into Asx-turn 
conformation, it is highly likely that this is indeed the bioactive 
conformation. 
CONCLUSIONS 
Hexapeptides fixed into ~-turn conformations were shown to 
be relatively poor acceptors for glycosylation. Instead, the 
bioactive conformation was demonstrated to be an Asx-turn. 
Further analogs which fix the Asx-turn while containing only one 
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putative glycosylation site are required before the enzymatic 
properties can be evaluated definitively. 
150 
Appendix 5-1 Enzyme kinetic data for Bz-NLT-NHMe 
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Appendix 5·2 Enzyme kinetic data for Bz-NLT-NHMe 
(200,000 dpm Dol-P-P-G1cNAc-[3HlGlcNAc) 
[ 
" 
dpm/min Bz-NLT-NHMe (200,000 dpm) 
~O --y = 2105 + 207.3x R= 0.61273 
-><-0.05 --y = 1828.3 + 405.81x R= 0.99683 
-"-0.1 --y = 2429.7 + 715.1x R= 0.9936 
--+-0.2 --y = 2410.9 + 1255.8x R= 0.99346 
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Appendix 5-3 Enzyme kinetic data for cyclo(PY dNGTL) 
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Appendix 5-4 Enzyme kinetic data for cyclo(CANCTSA) 
(200,000 dpm Dol-P-P-G1cNAc-[3H1GlcNAc) 
dpm/min CANCTSA 
~ 
~ CANCTSA 4 mM --y = 3609.5 + 4425.2x R. 0.99707 
__ CANCTSA2mM --y ~ 2922 + 3641.4x R. 0.99612 
---6-CANCTSA 1 mM --y = 1928.1 + 2082.5x R. 0.99434 
-+-CANCTSAO.5mM --y = 3779.4 + 1129.5x R= 0.98795 
- 0- CANCTSA .2 mM _. - y • 1345.5 + 573.75x R. 0.99594 
25000 
KmCANCTSA 































Appendix 5-5 Enzyme kinetic data for cyc1o(CYNCTSY) 
(200,000 dpm Dol-P-P-GlcNAc-[3HlGlcNAc) 
dpm/min CYNCTS V 
~2mM --y = 3076 + 5362.1x R= 0.99818 
___ 1 mM --y = 1582 + 5443.8x R= 0.99948 
---'-0.4mM --y = 5441 .7 + 3182.3x R= 0.98654 
-+-0.2mM --y = 3266.5 + 2338.2x R= 0.99664 
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Appendix 5-6 Enzyme kinetic data for pimelic macrocycie 
(200,000 dpm Dol-P-P-G1cNAc-[3H]GlcNAc) 
dpm/min pimelic macrocyc)e 
__ 3.75 --y = 2485 + 227.7. R. 0.99526 
__ 1.25 --y = 1639.7 + 194.75. R. 0 .99991 
-6- .5 --y = 3036 + 104.15. R= 0.93478 









5 10 15 20 25 30 35 40 45 
minut .. 
Km Pimelic maCfOcycle 










-1 0 2 3 4 
• 
156 
Appendix 5-7 Enzyme kinetic data for Ac-NLT-OMe 
(200,000 dpm Dol-P-P-G1cNAc-[3HlGIcNAc) 
dpm/min Ac-NLT-OMc 
.......-10 mM --y.: 6465 + 412.25x R: 0.99685 
-+<-5mM --y: 3289 + 287.34x R~ 0.99778 
__ 2.5 mM --Y = 3349.4 + 23O.92x R. 0 .99958 
-+-1 mM -- y = 3303.4 + 106.62x R. 0 .99969 
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As discussed in the preceeding chapters, the central reaction 
in N-Iinked glycosylation is catalyzed by oligosaccharyl 
transferase and culminates in the formation of the primary bond 
between carbohydrate and protein. Overall, a complex 
carbohydrate moiety is transferred to an asparagine residue 
which is located within the consensus triad -Asn-Xaa-Thr/Ser-
(Figure 6-1) . The mechanism of this transfer is not fully 
understood but appears to involve nucleophilic attack by the 
carboxyamido group of the asparagine at the sp3 anomeric carbon 
of the sugar. 
HOI H 0 
KN~N~N~ 
. H 0 -
OH
O 






Figure 6-1 Overall reaction catalyzed by oligosaccharyl 
transferase. 
Little mechanistic information regarding this transfer step is 
available for two reasons: 1) the purification of this membrane 
bound enzyme is treacherous and 2) once removed from its lipid 
environment the enzyme is extremely unstable. 
Until the enzyme can be purified in its active form, specific 
information regarding the mechanism of the oligosaccharide 
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transfer step must be gleaned from substrate studies of the lipid-
linked oligosaccharide donor and of the polypeptidyl acceptor. 
The transfer of carbohydrate from the lipid donor to the 
peptidyl acceptor occurs with inversion of configuration at the 
anomeric center. This process could occur in a one-step 
displacement reaction with the carboxyamido nitrogen attacking 
Cl of N-acetylglucosamine with concomitant displacement of 
dolichol pyrophosphate (Figure 6-2). 
RO 
HOI H 0 
r N0N'''yN0 
: H 0 A 
H~-( OH 
OH . ) 0 
o OJigosaccharyl .. 
OH 0 0 transferase 
OH II II 
o I I 
OH AcHN 0- O-
NHAc 
Figure 6-2 Concerted mechanism 
glycoprotein 
Alternatively, the reaction could proceed via an oxocarbonium 
sugar intermediate, generated by cleavage of the carbon-oxygen 
bond, with subsequent attack by the amide nitrogen (Figure 6-3). 
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OH 
• 1---_ glycoprotein 
6) 
OH OH ~~ 
OH AcHN 6- 6-
RO 
NHAc 
Figure 6-3 Two step mechanism 
The oxocarbonium species may be stabilized by the neighboring 
N-acetyl group_ A similar two step mechanism has been proposed 
for the reaction catalyzed lysozyme, a l3-glucosidase (1)-
Lysozyme catalyzes the hydrolysis of a polysaccharide composed 
of alternating 13(1,4) linked units of N-acetylglucosamine and N-
acetylmuramic acid_ The reaction proceeds with retention of 
configuration (Figure 6-4)_ 
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Figure 6-4 Proposed reaction pathway catalyzed by lysozyme. 
A glutamate residue located at the active site weakens the J3( 1,4) 
bond by withdrawing electron density into a hydrogen bonding 
interaction. A second residue, aspartate, electrostatically stablizes 
the oxocarbonium ion intermediate which forms in the bond 
breaking step. This intermediate is highly electrophilic and is 
readily attacked by water. The intermediate is characterized by 
a half-chair conformation and a sp2 center within the ring. 
Evidence supporting this mechanism was provided by the 
inhibition of lysozyme with a transition state analog, tri-N-




Figure 6-5 Structure of tri-N-acetylglucosaminyl-N-
acetylglucosamine lactone (R=GIcNAc). 
The two-step lysozyme-like mechanism proposed for 
glycosylation has never been demonstrated. Stereochemically, 
the mechanism does not require formation of the oxocarbonium 
species since the product, containing an a( 1,4) linkage, would be 
generated by direct attack with inversion of configuration; 
however, a two step mechanism cannot be ruled out. 
Central to understanding the mechanism of N -glycosylation 
is ascertaining how the reactivity of a relatively poor nucleophile, 
the carboxyamido group, can be enhanced. Amides are planar and 
resonance stabilized. Since nitrogen's lone pair of electrons are 
involved in a x-bonding interaction with carbon, the 
nucleophilicity of nitrogen is reduced. To increase the amide-
nitrogen nucleophilicity, the amide resonance interaction must be 
disrupted. 
One way of disrupting the amide resonance interaction is 
through a hydrogen bonding array. The necessity of a hydroxyl 
amino acid two residues away from the asparagine has prompted 
several researchers to postulate that this residue functions as 
either a hydrogen bond donor or acceptor. Bause and Legler 
proposed that a general base near the active site could remove the 
proton from the ~-hydroxyl oxygen (2). The resulting oxyanion 
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would be strongly nucleophilic and could subsequently abstact a 
proton from the l3-carboxyamido nitrogen of the asparagine 
(Figure 6-6). This would render the asparagine sufficiently 








:-H~---0\r NH H-0\r H 0 
R .... 
N 




H H 0 H H 0 0 0 
Figure 6-6 Bause's proposed activation of the carboxyamido 
nitrogen. 
This proton relay system would explain the observed differences 
in the glycosylation rates of cysteine, serine, and threonine (Table 
6-1) (2). 
Table 6-1 Glycosyl acceptor capabilities of hexapeptides in the 
series Tyr-Asn-Gly-Xaa-Ser-Val. Relative transferase 
activity (Vmax/Km) was based on the serine-containing 
'd pepu e. 
relati ve 
Xaa Km (mM) Vmax transferase 
(cpm/lO min) activity 
Thr 0 .16 2080 40 
Ser 1.6 550 1 
CyS - - O.4a 
Val - - -
Thr(OMe) - - -. . a resldual activity was eVldent at hlgh concentratIOns of peptide . 
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These results showed that serine-, threonine-, and cysteine-
containing peptides could be glycosylated, although at very 
different rates, whereas valine- and O-methylthreonine-
containing peptides were not substrates. The observed 
differences in the transfer rates (cys < ser < thr) are compatible 
with the decreasing efficiency of these residues to serve as 
hydrogen bond acceptors. Thus there appears to be an absolute 
requirement connected with the hydrogen bond donor ability of 
the hydroxyl amino acid. 
In an earlier attempt to interpret the acid-base titration 
behavior of glycopeptides, Marshall constructed a different 
hydrogen bonding array (3). In this model, the hydroxyl group of 
the hydroxyl amino acid is involved in a hydrogen bond with the 




Figure 6-7 An alternate hydrogen bonding array proposed by 
Marshall. 
Under these conditions a nucleophilic attack on the lipid-linked 
oligosaccharide would only be expected when it is preceeded by 
abstraction of a proton from the amide group. However, initial 
deprotonation is unlikely due to the relatively low base strengths 
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of the likely candidates (thiolate, carboxylate, imidazole) 
compared to the pKa (14-15) of the carboxyamido nitrogen donor. 
Another possible mode of disrupting the amide resonance 
and thereby increasing the carboxyamido nucleophilicity is 
through the addition of a nucleophile to the carbonyl carbon to 
generate a tetrahedral intermediate. Breakdown of this 
intermediate with expUlsion of the amide nitrogen would result in 
production of nucleophilic ammonia and an acyl derivitive of the 
nucleophile. This scheme is analogous to the well-established 
mechanism for glutamine-dependent amino transfer reactions (4) 
and has been recently suggested for the glycosyl transfer reaction 
(5). 
In this proposal, asparagine IS activated by an enzyme 
bound base and deaminates to form an enzyme bound acyl 
intermediate with release of ammonia. Subsequent nucleophilic 
displacement of pyrophosphyldolichol by ammonia generates an 
intermediate I-amino oligosaccharide. This intermediate then 
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Figure 6-8 Reaction mechanism proposed by Clark et al. 
The downfall of this mechanism is that it neither profers a role for 
the essential hydroxy amino acid residue in the transfer reaction, 
nor does it attempt to explain the specificity observed for the 
reaction. 
The former mechanistic proposals which incorporate 
hydrogen bonding arrays are more likely because they not only 
require the hydroxy residue but also have stabilized secondary 
structures. In the preceeding chapters it was demonstrated that 
the conformation of the polypeptidyl acceptor is a crucial element 
in glycosylation. The conformation of the polypeptidyl acceptor 
establishes a microenvironment surrounding the carboxyamido 
group which may subtly govern the specificity observed in 
glycosylation. 
In chapters 3 to 5, the dominant solution conformation of 
the peptidyl acceptors examined was shown to be an Asx-turn. 
This structure is formed via a hydrogen bonding interaction 
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between the carbonyl oxygen of the asparagine side chain and the 
amide proton of the hydroxy residue. The Asx-turn is a common 
structural motif found in proteins. When the glycosylation triad 
exists in this conformation, the carboxyamido oxygen and the 
hydroxyl proton are within hydrogen bonding distance. Thus if 
hydrogen bonding interactions provide a means of inducing 
specificity into the mechanism, they are probably best depicted 





Figure 6-9 The hydrogen bonding array which is 
conformationally consistent with an Asx-turn. 
This array contains a second hydrogen bond between the side 
chain carbonyl oxygen of asparagine and the hydroxyl proton of 
the hydroxy amino acid. This added hydrogen bonding interaction 
may serve both to further stabilize the Asx-turn and to align the 
hydroxyl proton with the more basic lone pair of electrons of the 
carbonyl oxygen. 
This chapter summariies the use of peptidyl analogs to 
probe the catalytic mechanism of N-glycosylation. We have 
170 
synthesized a number of tripeptides that differ from one another 
by replacement of the essential residues, Asn and Thr/Ser, with 
various unnatural amino acid residues. 
EXPERIMENTAL METIIODS 
Peptide Synthesis 
All peptides were synthesized using standard solution phase 
methods (6). Coupling reactions were performed with 
DCCIHOBT/triethylamine in THF or DMF at a minimum reagent 
concentration of 0.1 M. 
Bz-Ala(J3-cya no) -Le u -Thr- N H Me 
BOC-Ala(J3-CN) was prepared in 72% yield from Ala(J3-CN) 
with BOC-ON and triethylamine in dioxane-water. BOC-Leu.H20 
was reacted with Thr-OMe.HCI using DCC/HOBT/triethylamine in 
DMF to afford BOC-Leu-Thr-OMe in 90%. BOC-Leu-Thr-OMe was 
deprotected with trifluoroacetic acid and dichloromethane 
followed by the reaction with BOC-Ala(J3-CN) and 
DCC/HOBT/triethylamine and BOC-Ala(J3-CN)-Leu-Thr-OMe was 
obtained in 88%. Then the reaction with methylamine in 
methanol gave 45% of BOC-Ala(J3-CN)-Leu-Thr-NHMe. BOC group 
was removed as described previously. Subsequent reaction with 
benzoic anhydride and triethylamine in DMF yielded 60% of Bz-
Ala(J3-CN)-Leu-Thr-NHMe after purification (PTLC eluent 5:1 
chloroform/methanol). 
IH NMR (d6-DMSO) Ii: 0.81 (3H, d, J=6.5 Hz); 0.84 (3H, d, J=6.5 Hz); 
0.98 (3H, d, J=6.3 Hz); 1.48 (2H, m); 1.59 (lB, m); 2.58 (3H, d, 
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1=4.6 Hz); 2.94 (lH, dd, 1=10.3, 16.8 Hz); 3.02 (IH, dd, 1=4.7, 
16.8 Hz); 3.96 (lH, m); 4.08 (lH, dd, 1=3.9, 8.7 Hz); 4.32 (lH, 
m); 4.82 (lH, m); 7.50 (2H, t, 1=8.1 Hz); 7.56 (lH, d, 1=7.3 Hz); 
7.61 (lH, d, 8.1 Hz); 7.59 (IH, d, 1=8.7 Hz); 7.88 (2H, d, 1=7.4 
Hz); 8.28 (lH, d, 1=7.9 Hz); 8.96 (IH, d, 1=8.1 Hz). 
13C NMR (d6-DMSO) 0: 19.89, 21.47, 22.99, 24.05, 25.55, 40.21, 
49.57, 51.76, 58.10, 66.36, 118.18, 127.43, 128.28, 131.64, 
133.49, 166.66, 168.79, 170.19, 171.64. 
High resolution MS [M+] Calcd. for C22H32NSOS: 446.2403, obsd. 
446.2415 . 
Bz-Ala-[~- (C S NH2)]- Leu-Thr- N HM e 
Bz-Ala(J3-cyano)-Leu-Thr-NHMe (0.208 mmol, 92.8 mg) was 
placed in a flask and 4 mL of saturated ammonia solution in 
absolute ethanol (4.3 M) was added. Then hydrogen sulfide was 
introduced to the reaction mixture at O°C. The solution was 
stirred at room temperature for one day and the solvent was 
removed. Dry methanol was added to the mixture and sulfur was 
filtered out. Then the mixture was purified with PTLC (silica, 
chloroform/methanol 8/1) and 53.6 mg (53%) of thioamide was 
obtained. The compound was further purified by recrystallization 
from methanol/chloroform/hexane (1/1/10) which afforded 
analytically pure thioamide as a white solid (33 mg, 33%). 
IH NMR (d6-DMSO) 0: 0.81 (3H, d, 1=6.4 Hz); 0.85 (3H, d, 1=6.5 Hz); 
0.98 (3H, d, 1=6.3 Hz); 1.49 (lH, m); 1.52 (lH, m); 1.58 (lH, 
m); 2.59 (3H, d, 1=4.5 Hz); 2.97 (2H, br s); 3.98 (lH, m); 4.05 
(lH, m); 4.33 (lH, m); 4.84 (IH, d, 1=5.1 Hz); 4.96 (lH, m); 
7.49 (2H, t, 1=7.5 Hz); 7.54 (IH, t, 1=7.4 Hz); 7.59 (lH, d, 1=8.7 
Hz); 7.84 (2H, d, 1=7.5 Hz); 8.11 (lH, d, 8.0 Hz); 8.59 (lH, d, 
1=7.7 Hz); 9.15 (lH, s); 9.54 (lH, s). 
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13C NMR (d6-DMSO) 0: 19.91, 21.42, 23.15, 24.05, 25.58, 39.00, 
40.20, 45.06, 53.28, 58.22, 66.29, 127.39, 128.18, 131.19, 
133.96, 166.50, 170.22, 170.70, 171.88, 203.98. 
High resolution MS [M+]. Calcd. for C22H34NSOSS: 480.2281, obsd. 
480.2269. 
Bz-Ala([3-[C(NHz)=NH.HCI])-Leu-Thr-NHMe (Bz-Tan-Leu-Thr-NHMe) 
Under nitrogen atmosphere, A saturated HCI solution in 
absolute ethanol (8.6 M, 2 mL) was added to Bz-Ala([3-cyano)-
Leu-Thr-NHMe (58.2 mg, 0.131 mmol) at O°C. The solution was 
stirred at that temperature for 1 h until no starting material 
remained by TLC (silica, chloroform:methanol=5:1). The solvent 
was removed with nitrogen flow at room temperature. Care was 
taken to avoid moisture. The mixture was dried in vacuo after 
which a saturated ammonia solution in absolute ethanol (4.3 M, 2 
mL) was added at RT. After stirring 1 h at O°C, the mixture was 
concentrated and dissolved in distilled water (5 mL) and washed 
with chloroform (3 x 5 mL). Water was removed and the 
resulting solid was purified via preparative HPLC. 
IH NMR (d6-DMSO) 0: 0.84 (d, 3H, 1=6.3Hz), 0.87 (d, 3H, 1=6.3Hz), 
0.96 (d, 3H, 1=6.4Hz), 1.51 (m, 2H), 1.55 (m, lH), 2.54 (d, 3H, 
1=4.5Hz), 2.80 (dd, lH), 2.98 (dd, lH), 3.99 (m, lH), 4.09 (m, 
lH), 4.40 (m, lH), 4.85 (m, lH), 7.48 (t, 2H, 1=7.5Hz), 7.56 (t, 
lH, 1=7.4Hz), 7.56 (d, lH, 1=4.6Hz), 7.69 (d, lH, 1=8.6Hz), 7.87 
(d, 2H, J=-7.5Hz), 8.24 (d, IH, J=8.4Hz), 8.75 (br s, 2H), 8.76 
(d, lH, J=7.2Hz), 8.86 (br s, 2H). 
13C NMR (d6-DMSO) 0: 19.97, 21.41, 23.09, 24.15, 25.59, 28.35, 
34.39, 40.43, 51.44, 51.68, 58.39, 66.24, 127.56, 128.27, 
131.73, 133.46, 166.95, 167.86, 169.47, 170.30, 171.79. 
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High resolution MS [M+]. Calcd. for C22H35N605: 463.2669, obsd. 
463.2663. 
Hz-y-Aminobutyrine-Leu-Thr-NHMe (B z-Amb-Leu- Thr-NHMe) 
Bz-Ala(CN)-Leu-Thr-NHMe (20 mg, 0.046 mmol) was 
dissolved in 3.6 mL methanol/acetic acid/chloroform (3/0.1/0.5). 
Under nitrogen atmosphere, 50 mg of 5% Pd/carbon was added 
and the solution was then stirred under atmospheric hydrogen 
pressure for 8 h. At this time the reaction mixture was filtered 
and the product purified by PTLC (chloroform: methanol 5: 1). The 
reaction afforded 13 mg (59% yield) of the target amine as a white 
solid. 
IH NMR (d6-DMSO) 15: 0.84 (d, 3H, J=6.3 Hz); 0.88 (d, 3H, J=6.4 Hz); 
0.98 (d, 3H, J=6.1 Hz); 1.50 (m, 2H); 1.63 (m, lH); 1.99 (m, 
lH); 2.07 (m, lH); 2.59 (d, 3H, J=4.2 Hz); 2.90 (m, 2H); 3.96 
(m, lH); 4.09 (m, lH); 4.35 (m, lH); 4.54 (m, lH); 4.83 (d, 1H, 
J=4.7 Hz); 7.47 (t, 2H, J=7.4 Hz); 7.55 (t, lH, J=7.1 Hz); 7.65 (d, 
IH, J=4.5 Hz); 7.66 (d, lH, J=8.9 Hz); 7.76 (br s, 2H); 7.88 (d, 
2H, J=7.5 Hz); 8.15 (d, lH, J=7.6 Hz); 8.63 (d, lH, J=7.5 Hz). 
13C NMR (d6-DMSO) 15: 19.88,21.41,23.05, 24.09, 25.51, 29.63, 
36.22, 40.59, 51.20, 51.60, 58.33, 66.40, 127.55, 128.12, 
131.37, 133.81, 166.63, 170.31, 170.84, 171.90. 
High resolution MS [M+]. Calcd. for C22H36N505: 450.2716, obsd. 
450.2715. 
Hz-Asp- Leu-Thr-NHMe 
1H NMR (d6-DMSO) 15: 0.801 (d, 3H, J= 6.4 Hz), 0.839 (d, 3H, J= 6.6 
Hz), 0.972 (d, 3H, J= 6.4 Hz), 1.483 (m, 2H), 1.586 (m, lH), 
2.580 (d, 3H, J= 4.7 Hz), 2.686 (dd, lH, J= 16.8 Hz, 9.1 Hz), 
2.802 (dd, lH, J = 16.7 Hz, 5.0 Hz), 3.978 (m, 1H), 4.061 (dd, 
lH, J = 8.6 Hz, 3.7 Hz ), 4.301(m, lH), 4.782 (m, lH), 7.483 
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(m, 2H), 7.530 (m, 3H), 7.840 (d, 2H, J= 8.5 Hz), 8.104 (d, IH, 
J= 8.0 Hz), 8.696 (d, lH, J= 7.5 Hz). 
l3C NMR (d6-DMSO) 0: 19.93, 21.48, 23.07, 24.10, 25.62, 35.62, 
35.64, 50.29, 51.64, 58.20, 66.27, 127.46, 128.17, 131.37, 
133.93, 166.55, 170.24, 170.85, 171.85, 171.91 
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Bz-Asp(y-OMe)-Leu-Thr-NHMe (7) 
1 H NMR (d6-DMSO) 0: 0.804 (d, 3H, J=6.6 Hz), 0.843 (d, 3H, J=6.6 
Hz), 0.976 (d, 3H, J= 6.3 Hz), 1.486 (m, 2H), 1.600 (m, lH), 
2.583 (d, 3H, J=4.5 Hz), 2.763 (dd, lH, J=16.5 Hz, 8.9 Hz), 
2.887 (dd, 1 H, J=16.5 Hz, 5.5 Hz), 3.587 (s, 3H), 3.981 (m, 
lH), 4.069 (dd, lH, J=8.6 Hz, 3.7 Hz), 4.301 (m, IH), 4.831 (m, 
2H), 7.468 (t, 2H, J=7 .6 Hz), 7.539 (m, 3H), 7.837 (d, 2H, J=8.5 
Hz), 8.152 (d, lH, J=8 .0 Hz), 8.722 (d, lH, J=7.7 Hz). 
l3C NMR (d6-DMSO) 0: 19.91, 21.48, 23 .04, 24.08, 25.51, 35.36, 
35.40, 50.06, 51.49, 51.68, 58.13, 66.27, 127.43, 128.18, 
131.40, 133.86, 166.55, 170.19, 170.50, 170.76, 171.83 
High resolution MS [M+] = Calculated for C23H34N407: 479.2506; 
observed: 479.2504. 
Bz-Asn([3-NHMe)-Leu-Thr-NHMe (7) 
IH NMR (d6-DMSO) 0: 0.797 (d, 3H, J=6.5 Hz), 0.848 (d, 3H, J=6.5 
Hz), 0.991 (d, 3H, J=6.5 Hz), 1.504 (m, 2H), 1.601 (m, lH), 
2.567 (d, 3H, J=4.5 Hz), 2.570 (m, lH), 2.586 (d, 3H, J=5.0 Hz), 
2.689 (dd, lH, J=6.3 Hz, J=15.3 Hz), 4 .001 (m, IH), 4.068 (m, 
lH), 4.293 (m, lH), 4.750 (m, lH), 4.804 (d, IH, J=5.5 Hz ), 
7.452 (m, 2H), 7.542 (m, 2H), 7.591 (d, lH, J=8.5 Hz), 7.826 
(d, 2H, J=7.5 Hz), 7.897 (d, IH, J=4.5 Hz), 8.187 (d, lH, J=8.0 
Hz), 8.628 (d, lH, J=8.0 Hz) 
l3e NMR (d6-DMSO) 0: 19.97, 21.34, 23 .08, 24.07, 25.52, 25.62, 
36.76, 50.71, 51.67, 58.40, 66.30, 127.36, 128.21 , 131.35, 
133.98, 166.37, 170.09, 170.29, 171.10, 171.98 
Mass Spectroscopy [MH]+ 478 
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Bz-Asn-Leu-allo(Thr) - N H M e 
1H NMR (d6-DMSO) 15: 0.81 (dd, 6H, J=6.6 Hz), 1.00 (d, 3H, 6.3 Hz), 
1.4 (m, 2H), 1.6 (m, 2H), 2.5 (d, 3H, J=4.4 Hz), 2.55 (m, 2H), 
3.8 (m, lH), 4.06 (m, 2H), 4.25 (m, 1H), 4.85 (m, lH), 4.86 
(bs, lH), 7.0 (s, lH), 7.3 (s, lH), 7.46 (m, 3H), 7.52 (m, 1H), 
7.76 (m, lH), 8.1 (d, lH, J=7.6 Hz), 8.62 (d, lH, J=7.6 Hz) 
Mass Spectroscopy [MH]+ 465 
Bz-Asn-Leu-Ser-N HMe 
IH NMR (d6-DMSO) 15: 0.8 (dd, 6H, J=6.4 Hz), 1.6 (m, 3H), 2.65 (m, 
2H), 3.3 (s, lH), 4.2 (m, lH), 4.8 (m, lH), 7.4 (m, 3H), 7.6 (m, 
3H), 7.8 (lH, d, J=7.4 Hz), 7.9 (lH, d, J=7.6 Hz) 
Mass Spectroscopy [MH]+ 451 
Bz-Asn-Leu- Val-NHMe 
IH NMR (d6-DMSO) 15: 0.80 (d, 9H, J=6.6 Hz), 0.84 (d, 3H, J=6.5 Hz), 
1.46 (m, 2H), 1.59 (m, lH), 1.94 (m, lH), 2.56 (d, 3H, J=4.4 
Hz), 2.57 (dd, lH), 2.63 (dd, lH, J=5.9, 15.6 Hz), 4.02 (m, lH), 
4.34 (m, lH), 4.74 (m, lH), 6.95 (s, 1H), 7.37 (s, 1H), 7.46 (t, 
2H, J=7.4 Hz), 7.53 (t, lH, J=7.0 Hz), 7.63 (d, lH, J=9.1 Hz), 
7.75 (d, lH), 7.83 (d, 2H, J=7.7.4 Hz), 8.08 (d, lH, J=8.1 Hz), 
8.59 (d, lH, J=7.8 Hz) ppm. 
Mass Spectroscopy [MH]+ 463 
RESULTS AND DISCUSSION 
The transfer kinetics of eight peptides (Bz-Asn-Leu-Ser-
NHMe, Bz-Asn-Leu-allo(Thr)-NHMe, Bz-Asn-Leu-Thr-NHMe, Bz-
Asp-Leu-Thr-NHMe, Bz-Asp(y-NMe)-Leu-Thr-NHMe, Bz-Asp(y-
OMe)-Leu-Thr-NHMe, Bz-Tam-Leu-Thr-NHMe, and Bz-Amb-Leu-
Thr-NHMe) were determined using standard assay conditions and 
were compared against the standard substrate, Bz-Asn-Leu-Thr-
176 
NHMe, to probe for relative enzymatic activity. These peptides 
were categorized as containing either a modification of the 
hydroxyl amino acid or of the asparagine residue. 
The first three peptides were designed to probe the 
importance of the hydroxyl group as a binding determinant. The 
importance of the proton acceptor ability of the hydroxy residue 
was discussed early. The observed differences in the 
glycosylation rates of pep tides containing modified hydroxy 
residues within the marker sequence was related to the decrease 
in base strength of the hydrogen bond acceptor functions 
(cysteine < serine < threonine). However the particular efficiency 
of the threonine-containing peptide compared to the serine-
containing peptide (4011) is not fully explainable with this 
rationale. To probe for binding interactions between the hydroxyl 
group and the enzyme, the stereochemistry of the hydroxy 
residue was varied. The kinetic data for these peptides is shown 
in Table 6-2. 
Table 6-2 Glycosyl acceptor properties of tripeptides contammg 
sterically modified hyroxyl amino acids within the 
series Bz-Asn-Leu-Xaa-NHMe 
oeD tide Km (mM) V max dnm min- 1 Vmax/Km Ki (mM) 
Bz-NLT-NHMe 0.47 4208 8953 -
Bz-NLS-NHMe 3.3 507 154 -
Bz-NL·lloT-NHMe - - - >10 
Bz-NLV-NHMe - - - >10 
Although the peptide formed by substitution of the 
hydroxyl group with a methyl group (Thr-t Val) is sterically 
similar to the standard substrate, the glycosyl acceptor ability is 
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abolished. Furthermore, the peptide no longer binds to the 
enzyme as evidenced by inhibition studies with Bz-NLT-NHMe. 
No inhibition is evident at either low or high concentrations of 
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Figure 6-10 Inhibition study of Bz-NLT-NHMe by Bz-NLV-
NHMe. 
Examination of the 2-D ROESY spectra of Bz-NLV-NHMe indicated 
that the peptide exists predominantly in solution as an Asx-turn. 
Thus the hydroxyl group must make important binding 
interactions with the enzyme. 
The position of the hydroxyl group also appears to affect 
binding. The sole modification in Bz-Asn-Leu-(allo)Thr-NHMe 
occurs at the Thr Il-carbon. The stereochemistry of the a,ll 
positions in naturally occurring threonine is (S), (R); in (allo)Thr it 
is (S), (S). This modification also resulted in a compound which 
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was a non-binder (non-acceptor, no inhibition). This suggests that 
the hydroxy residue may bind within a chiral pocket located on 
the surface of the transferase. The existence of such a pocket 
would explain the dramatic increase in efficiency of threonine-
containing sites as compared to serine-containing sites. If a chiral 
pocket exists, the additional methyl group could serve to restrict 
rotation of the hydroxyl group, favorably positioning the hydroxyl 
proton for a hydrogen bonding interaction. 
The balance of the peptides examined were used to probe 
for chemical features which are essential to the acceptor ability of 
the asparagine residue. Modifications which were designed to 
subtly alter the environment surrounding asparagine are shown 
in Table 6-3. 
Table 6-3 Glycosyl acceptor properties of tripeptides containing 
II dT d . ·d stenca IV mo I Ie asparae;me resl ues. 
peptide Km (mM) Y max dom min-l Ymax/Km Ki (mM) 
Bz-NLT-NHMe 0.47 4208 8953 -
Bz-DLT-NHMe - - - >10 
Bz-D(OyMe)LT-NHMe - - - >10 
Bz-N(NyMe)LT-NHMe - - - >10 
It has long been known that -Gln-Xaa-Thr- sites are not 
recognized as acceptor sites despite the fact that glutamine differs 
from asparagine by only one methylene unit. This may be 
because glutamine does not form a stable short-range side chain 
to main chain interaction similar to the Asx-turn. Consequently 
although -Gln-Xaa-Thr- sequences possess identical functionality 
to the marker sequence they cannot adopt a similar conformation. 
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Moreover, -Asp-Xaa-Thr- sites also are not recognized as 
acceptor sites. Bz-DLT-NHMe was neither an acceptor nor an 
inhibitor in the transferase assay although it contains the "active" 
hydroxy amino acid, Thr, and is expected to adopt an Asx-turn 
conformation. This suggests that a full negative charge is not 
tolerated by the active site. Accordingly, the mechanism 
suggested by Bause and Legler (Figure 6-6) in which a full 
negative charge is induced at nitrogen by the abstraction of a J3-
carboxyamido proton is unlikely since Bz-DLT-NHMe mimics the 
charge distribution expected for this transition state and thus 
should inhibit the transferase. 
Bz-D(OyMe)LT-NHMe and Bz-N(NyMe)LT-NHMe likewise are 
non binders in the transferase assay although they also contain 
threonine and also are expected to adopt an Asx-turn 
conformation. This was surprising because neither modication 
was expected to deleteriously affect either the conformation of the 
peptide or the hydrogen bonding interaction between the 
asparaginyl carbonyl oxygen and the hydroxyl proton. However, 
both modifications did drastically alter the proton donor ability of 
the carboxyamido group. Thus it also appears that the proton 
donor ability of asparagine is essential for binding. 
A mechanism consistent with these findings is shown In 
Figure 6-11. 
180 
Figure 6-11 Proposed mechanism of N-linked glycosylation 
consistent both with conformational and 
mechanistic data. 
The side chains of asparagine and the hydroxy amino acid are 
brought into proximity by formation of a stabilized Asx-turn . 
Both the hydroxyl group and the backbone amide of the hydroxy 
amino acid interact with the carbonyl oxygen and increase the 
acid dissociation constant of the amide protons by stabilizing the 
alternate tautomer, the imidate. A general base at the active site 
can then abstract a proton from the carboxyamido nitrogen, 
thereby generating electron density at nitrogen and providing a 
means for nucleophilic attack at the CI sugar of the lipid-linked 
oligosaccharide. This mechanism relies on the peptide backbone 
either 1) to catalyze formation of the alternate tautomer or 2) to 
stabilize the alternate tautomer, thus any modifications which 
promote the formation of the imidate should result in more 
efficient acceptors. 
The following modifications affected the proton donor 
behavior of the carboxyamido nitrogen (Table 6-4). 
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Table 6-4 Glycosyl acceptor properties of tripeptides contaInIng 
asparagine analogs with altered proton donor 
behavior . 
peptide Km (mM) V max dom min-! Vmax/Km Ki (mM) 
Bz-NLT-NHMe 0.47 4208 8953 -
Bz-Amb-LT-NHMe - - - -1 
Bz-Tan-LT-NHMe 0.26 344 1323 -
Bz-Amb-LT-NHMe competitively inhibits the transferase 
and has a Ki comparable to the Km of the standard substrate, Bz-
NLT-NHMe. The proton donor in Bz-Amb-LT-NHMe has a lower 
pKa than the donor in the standard substrate, so it more readily 
donates a proton (Figure 6-12). 
) NH2 b) NH2 c) +NHa 
a RAo RAS R) 
pKa 14-15 pKa 13-14 pKa 10-12 
Figure 6-12 pKa values of a) Asn, b) Tan, and c) Amb. 
Amb lacks a carbonyl oxygen so it cannot form the necessary 
hydrogen bonding interactions to stabilize the recognized 
conformation, an Asx-turn; however it can achieve an analogous 
structure. Since the Ki of this inhibitor is similar to the Km, the 
increase in proton donor efficiency apparently compensates for 
the lack of stablized Asx-turn structure. 
Tan is the first example of a modified asparagine analog 
which functions as a substrate in glycosylation. The Km of Bz-Tan-
L T -NHMe was consistently shown to be slightly lower than Bz-
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NLT -NHMe indicating that this analog actually binds more 
efficiently to the enzyme. Sulfur is a weaker base than oxygen 
which causes the thioimidate tautomer to be less populated than 
the imidate tautomer. Consequently thioamides are stronger acids 
than carboxyamides and for this reason may bind more 
efficiently. The lower Vmax of Bz-Tan-LT-NHMe can also be 
related to the weaker basicity of sulfur. Since the thioimidate 
tautomer is less populated, the interconversion happens less 
frequently and thus the nucleophilic species is not generated as 
often. 
CONCLUSIONS 
The mechanism described above presents an ideal way for 
specificity to be generated in the glycosylation reaction despite 
the presence of seemingly more reactive groups within the 
protein. The backbone of the polypeptide acceptor not only forms 
a recognized conformation but it also catalyzes the formation of a 
nucleophilic species. The marker sequence must adopt an Asx-
tum conformation in order to function as an acceptor for 
oligosaccharyl transferase. This conformation enhances the 
reactivity of the asparagyl side chain carboxyamido group by 
promoting the formation of an imidate intermediate. Thus the 
specificity observed in N-glycosylation is generated by the 
conformation of the peptidyl acceptor. 
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Appendix 6-1 Enzyme kinetic data for Bz-NLT-NHMe 




dpm/min Bz-NLT-NHMe (200,000 dpm) 
__ 0 --y = 2105 + 207.3x R= 0.61273 
__ 0.05 -- Y = 1828.3 + 405.8" R= 0.99683 
-A--O.l --y = 2429.7 + 715." R= 0.9936 
--+--0.2 --y = 2410.9 + 1255.8x R= 0.99346 
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Appendix 6-2 Enzyme kinetic data for Bz-NLS-NHMe 
(200,000 dpm I>ol-P-P-G1cNAc-[3HjGlcNAc) 
dpm/min Bz-NLS-NHMe 
-0- NLS4mM - - y .. 672.69 + 255.96x R. 0.99598 
- -0- . NLS 2 mM - - - • y .. 11.m.7 + 164.37x R_ 0.99977 
. ·0· ·NLS 1 mM - . - -y .. 859.33 + 145.83x R_ 0.98698 
-M -NLSO.5mM - -y .. 1365.2 + 157.6x R_ 0.98342 
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Appendix 6-3 Enzyme kinetic data for Bz-Amb-LT-NHMe 
(200,000 dpm Dol-P-P-GlcNAc-[3H1GIcNAc) 
i-
Ki Bz-Am~l..T-NHMe 
-0- l tv 0 - - y .. 0.00033155 + 6.2'158-051( R_ 0.89115 
- .()- - l t v 0 .388 - - - . y .. 0 .00036703 + 9.46838-051( R_ 0.96836 
. -0 - - ltv 0.776 - - - -'I .. 0.00046735 + O .DOO1~21( R_ 0.98578 
---M -ltv 1.55 - -y .. O.0CI045535 + 0.0001571( R .. 0.98791 
-+-1/v3.1 y .. O.O~9878 + 0.00026841{ R_ 0.99808 
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Inhibition of Bz-NLT-NHMe by Bz-Amb-LT-NHMe 
-0- KmappJVmax - - 'J .. 6 .6243e-05 + 6 .~Sx R .. 0.99532 
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0 .00025 ./ 
./ 
./ 


















Appendix 6-4 Enzyme kinetic data for Bz-Tan-LT-NHMe 
(200,000 dpm Dol-P-P-GlcNAc-[3H1GlcNAc) 
dpm/min Bz-Tan-LT-NHMe 
-0- 2 TAN - - y _ 2135 + 294.89x R_ 0.99995 
- -0-·1 TAN - - - -y _ 2068.5 + 281 .97x R_ 0.99917 
• -<>- • 0.5 TAN - - - . y _ 1936.5 + 215.2)( R_ 0.99997 
---M -0.25 TAN - -y _ 1565.1 + 169.61)( R_ 0.99737 
- +- 0.125 TAN - - - y _ 1329.5 + 122.01lC R_ 0.99532 
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